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ABSTRACT OF DISSERTATION

DIFFUSE OPTICAL MEASUREMENTS OF HEAD AND NECK TUMOR
HEMODYNAMICS FOR EARLY PREDICTION OF CHEMO-RADIATION
THERAPY OUTCOMES

Chemo-radiation therapy is a principal modality for the treatment of head and neck
cancers, and its efficacy depends on the interaction of tumor oxygen with free radicals. In
this study, we adopted a novel hybrid diffuse optical instrument combining a commercial
frequency-domain tissue oximeter (Imagent) and a custom-made diffuse correlation
spectroscopy (DCS) flowmeter, which allowed for simultaneous measurements of tumor
blood flow and blood oxygenation. Using this hybrid instrument we continually measured
tumor hemodynamic responses to chemo-radiation therapy over the treatment period of 7
weeks. We also explored monitoring dynamic tumor hemodynamic changes during
radiation delivery. Blood flow data analysis was improved by simultaneously extracting
multiple parameters from one single autocorrelation function curve measured by DCS.
Patients were classified into two groups based on clinical outcomes: a complete response
(CR) group and an incomplete response (IR) group with remote metastasis and/or local
recurrence within one year. Interestingly, we found human papilloma virus (HPV-16)
status largely affected tumor homodynamic responses to therapy. Significant differences
in tumor blood flow index (BFI) and reduced scattering coefficient (μs’) between the IR
and CR groups were observed in HPV-16 negative patients at Week 3. Significant
differences in oxygenated hemoglobin concentration ([HbO2]) and blood oxygen
saturation (StO2) between the two groups were found in HPV-16 positive patients at
Week 1 and Week 3, respectively. Receiver operating characteristic curves were
constructed and results indicated high sensitivities and specificities of these
hemodynamic parameters for early (within the first three weeks of the treatment)
prediction of one-year treatment outcomes. Measurement of tumor hemodynamics may
serve as a predictive tool allowing treatment selection based on biologic tumor
characteristics. Ultimately, reduction of side effects in patients not benefiting from
radiation treatment may be feasible.
Key words: near-infrared, diffuse optics, head and neck cancer, papilloma virus status,
radiation therapy, tumor hemodynamics, prediction of treatment outcomes
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CHAPTER 1 INTRODUCTION
1.1 Head and Neck Cancers
Head and neck cancer accounts for about 3 to 5% of all cancers in the United
States with 40,000 new cases diagnosed each year [1, 2]. These cancers are more
common in men and in people over age 50. More than 90% of head and neck cancers
begin in the squamous cells that line the moist, mucosal surfaces inside the head and neck
area, e.g., oral cavity, pharynx (oropharynx, nasopharynx and hypopharynx), larynx,
paranasal sinuses and nasal cavity [3]. These head and neck squamous cell carcinomas
(HNSCC) frequently spread to the lymph nodes in the neck. The major risk factors for
HNSCC are tobacco use, alcohol consumption, and infection with human papillomavirus
(HPV); over 75 percent of head and neck cancers are caused by tobacco and alcohol use
[4]. Human papillomavirus (HPV) has been found in head and neck cancer from all sites
with a higher prevalence in oropharynx cancer [5]. The incidence of oropharyngeal
cancers caused by HPV infection in the United States is increasing [6]. In clinical
practice, HPV-16 immunohistochemistry (IHC) is recommended for detection of HPV
DNA in tumor cell nuclei [7].
1.2 Radiation Therapy
The three main types of treatment for managing head and neck cancer are
radiation therapy, surgery and chemotherapy. Radiation therapy is often used as the
principal modality in the treatment of head and neck cancers [8]. One significant
advantage of radiation therapy is that it allows for the possibility of organ preservation
when surgery may seriously affect important functions such as speech and swallowing. It
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is usually given in combination with chemotherapy (called chemo-radiation) if the stage
of the cancer is advanced (stage III or stage IV).

Figure 1.1 Direct and indirect action of x rays. In direct action a secondary electron
resulting from absorption of radiation interacts with the DNA to produce an effect. In
indirect action the secondary electron interacts with water molecules to produce free
radicals, which produce the damage to the DNA.
Although the exact mechanism is unclear, accumulating evidence suggests
double-stranded breaks of nuclear DNA as the most important cellular effect of radiation
therapy [9]. Damage to a cell can come from direct action or indirect action of the
ionizing radiation. In direct action a secondary electron resulting from absorption of
radiation interacts with the DNA to produce an effect. In indirect action the secondary
electron interacts with other atoms or molecules in the cell (particularly water) to produce
free radicals, which diffuse far enough to produce the damage to the DNA (Fig. 1.1). X
rays are considered low linear energy transfer (LET) (sparsely ionizing) radiation and
cause damage predominantly through indirect actions. Specifically, approximately two
thirds of DNA damage is caused by indirect action resulting from interaction of x rays
with water molecules which comprise the majority of the cell (80%) [10].
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A free radical is an atom or molecule carrying an unpaired electron in the outer
shell and is associated with a high degree of chemical reactivity. As an example of free
radical formation, when x rays pass through living tissue, first electrons are removed
from water molecules to produce H2O+ ions.
H2O + hν → H2O+ + e−
H2O+ is an ion radical because it is both an ion and a free radical. The ion radicals
have an extremely short lifetime (on the order of 10-10 second) and decay to then form the
free radicals, which are not charged but have an unpaired electron.
H2O+ +H2O → H3O+ + OH·
The hydroxyl radical, OH·, is a highly reactive free radical. It can diffuse a short
distance to attack DNA, break chemical bonds, and initiate chemical changes that results
in biological damage.
Radiation therapy tends to kill fast dividing cancer cells, but it also affects
dividing cells of normal tissues [11]. Radiation therapy is a balance between destroying
the cancer cells and minimizing damage to the normal cells.
1.3 Effects of Oxygen on Radiation Therapy
The radio-resistance of hypoxic cells to ionizing radiation is the primary reason
for treatment failure in tumors with high levels of hypoxia and is attributed to a reduction
in the amount of DNA damage under low oxygen conditions. DNA damage can be
chemically restored under hypoxia through reaction with a sulfhydryl (SH) group.
However, in the presence of molecular oxygen, oxygen fixes the radical lesions in DNA
in a form that cannot be easily repaired. This can be expressed as
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R·+ O2 → RO2·→ ROOH → Damage fixation

Cell death

This is known as the oxygen fixation hypothesis [11]. Here R·is the target (DNA)
free radical, which has arisen from direct or indirect radiation damage to the DNA of the
cell. The oxygen enhancement ratio (OER) is defined as the ratio of radiation doses
during lack of oxygen compared to no lack of oxygen for the same biological effect. The
OER for x rays is about 2.5 to 3 [11]. In other words, x-ray radiation is 2.5 to 3 times
more effective at killing cancer cells under well-oxygenated (normoxic) conditions as
compared with under hypoxic conditions. To exert its sensitizing effect, oxygen must be
present during or within milliseconds after the radiation exposure delivery of the
radiation dose [12]. The condition of the vascular ecosystem surrounding a tumor (tumor
microenvironment) can therefore greatly influence the efficacy of radiation therapy.
1.4 Tumor Hypoxia and Blood Supply (Flow)
Hypoxia is one of the most important features in the tumor microenvironment and
is often implicated as a primary cause of treatment failure following radiation therapy
[13]. As described above, it is associated with tumor radio-resistance. Hypoxia may also
lead to a reduction in levels of DNA repair proteins, potentially reducing DNA repair
capacity, and enhancing the possibility of genomic instability [14]. This genomic
instability can lead to tumor cell variants that can survive in an oxygen depleted
environment through clonal selection and expansion and result in a more clinically
aggressive phenotype with increased invasive capacity and higher propensity to
metastasize [15]. Furthermore, many chemotherapeutic agents are not able to penetrate
into the hypoxic zones that are located at a distance from the blood vessels, decreasing
the efficiency of chemotherapy [16].
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Figure 1.2 Tumor chronic and acute hypoxia. Blood vessels in malignant solid tumors
are chaotic, highly tortuous, often far apart, and have sluggish blood flow. Chronic
hypoxia results from an increase in diffusion distances with tumor expansion and acute
hypoxia is the result of the temporary closure or reduced flow in certain vessels.

Hypoxia arises as a result of an imbalance between the supply and consumption
of oxygen. Major causative factors of tumor hypoxia are abnormal vasculature, vascular
insufficiency, treatment or malignancy related anemia and increasing oxygen demands
for tumor growth [17]. Tumor hypoxia can be grouped into two distinct categories (Fig.
1.2) [18]. Chronic (diffusion-related) hypoxia is caused primarily by an insufficient
number of blood vessels and the oxygen supply to these cells is limited by diffusion
distance of oxygen through tissue that is respiring. Acute (perfusion-related) hypoxia
results from the temporary closing of a tumor blood vessel owing to the malformed
vasculature of the tumor. An important aspect of hypoxia in tumors is that it tends to be
very heterogeneous with some regions of a tumor showing low levels of hypoxia whereas
other regions demonstrate much higher levels [19].
Tumor microenvironments such as tumor oxygenation, vasculature and blood
supply (flow) are key factors for radiation treatment outcomes and prognoses in patients
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with head and neck cancer. Given the biological problems associated with tumor
oxygenation and blood flow, the goal for clinicians has been to identify poor prognosis
tumors for differential treatment strategies. Measurement of tumor hemodynamics may
serve as a predictive tool allowing treatment selection based on biologic tumor
characteristics. Ultimately, reduction of side effects in patients not benefiting from
radiation treatment will be feasible.
1.5 Techniques and Findings in Hemodynamic Measurements of HNSCC
The “gold standard” for detecting and characterizing of tumor hypoxia is the use
of invasive electrodes. The oxygen measurements involve inserting an electrode into a
tumor or metastatic lymph node and measuring oxygen from several points per needle
track in sub-millimeter steps. Each probe is reported to sample a tissue volume of about
50–100 cells. Typically, more than a hundred measurements are generated over the
accessible areas of the lesion, providing a composite overview of the lesion's hypoxia
status. Previous oxygen electrode studies have shown that tumor hypoxia is an adverse
prognostic factor in HNSCC [20-29]. However, this invasive method measures only a
tiny spot of tissue, making repeated measurements extremely difficult and often
producing inconsistent results in highly heterogeneous tumor tissues.
Immunohistochemical staining of tumor biopsy samples results in high-resolution
images that can be analyzed for several endogenous and exogenous markers of interest.
For example, pimonidazole is a hypoxia-specific marker. It is administered intravenously
prior to biopsy. High pimonidazole staining indicates a high level of tumor hypoxia and
is prognostic for poor clinical outcome in HNSCC [30]. As another example, HIF-1α
protein only exists in the hypoxic condition and is rapidly degraded by ubiquitination
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under normoxia. In most studies, HIF-1α overexpression is associated with poor
outcomes response to the treatment [31]. Therefore, HIF-1α is thought to be an
endogenous hypoxic marker and a prognostic predictor for the HNSCC. Unfortunately,
the tumor biopsy samples are often small and represent only a fraction of the entire
tumor. Furthermore, exogenous markers require intravenous administration before biopsy
samples can be taken. Finally, the acquisition of a tumor biopsy often requires the use of
general anesthesia, and this procedure is not attractive for repetitive measurements.
PET imaging using 18F-fluoromisonidazole (18F-FMISO) can be used to
quantify tissue hypoxia. Tumor to muscle ratio of 18F-FMISO has been found to be
significantly correlated with tumor hypoxic fraction as measured by the polarographic
electrode in head and neck cancer patients [32, 33]. Importantly, the level of hypoxia
depicted by 18F-FMISO PET before treatment was found to be correlated with localregional failure. Other studies demonstrated that PET imaging of hypoxia with 18FFMISO after one or two weeks of radiotherapy was correlated better with treatment
outcomes than imaging before treatment [34-36]. 15O-labeled water (15O-H2O) PET has
also been used for imaging of blood perfusion in patients with head and neck cancer [37].
Preliminary results indicated an association between tumor perfusions and radiation
treatment outcomes. However, PET involves the peripheral injection of invasive
radiotracers. Other limitations of PET techniques include limited ability of tracers to
freely access the tumor cells and their half-life in the circulation and tumor relative to the
radiological half-life of the PET isotope used.
Diffusion-weighted magnetic resonance imaging (DWI) is a form of MR imaging
based upon measuring the random Brownian motion of water protons within a voxel of
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biologic tissue. One recent study showed a significantly lower pretreatment apparent
diffusion coefficient (ADC) in lymph node metastases in complete responders than in
partial responders [38]. Monitoring of response to radiation therapy is the area where
DWI has the potential to make large impact on clinical managements. Early results
suggest that cancers that showed only a small increase or decrease in ADC during
treatment or in the early post-treatment phase are more likely to fail treatment [38-43]
and more interestingly, change in the ADC during therapy served as a better predictor
than baseline ADC alone [41, 42].
T1-weighted Dynamic Contrast-Enhanced MRI (DCE-MRI) is used to estimate
the flow, volume, and permeability of blood vessels in tumors. DCE-MRI has the
advantage that the whole tumor and lymph nodes can be analyzed voxel by voxel. Some
pilot studies using DCE-MRI in HNSCC found that a measure of hypoxia correlated
positively with the kinetic transport constant, Ktrans and hypoxia correlated negatively
with tumor blood flow [44, 45]. Tumors with large areas of lower blood volume (BV) or
impaired tumor perfusion were associated with local treatment failure [46]. Some studies
found low pretreatment Ktrans in regional lymph node metastases was associated with a
poor response to concurrent chemo-radiation therapy [47, 48]. Heterogeneity of
microvascular parameters has been demonstrated by DCE-MRI using voxel-by-voxel
analysis. One study showed that skewness of pretreatment Ktrans was the strongest
prognostic factor for outcome following chemo-radiation therapy [49].
Other MRI technologies have been developed to measure tissue perfusion.
Arterial spin labeling (ASL) is a MR perfusion technique that uses intra-arterial water as
an endogenous tracer and hence does not require administration of intravenous
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gadolinium. It has been widely applied for brain tumors, but there are only a few reports
regarding the use of ASL-MRI for patients with HNSCC. Blood oxygenation level
dependent (BOLD) MRI is generally a more sensitive measure of oxygen levels for
perfusion-related hypoxia than for diffusion-dependent hypoxia [50]. This technique is
still under development in patients with head and neck cancers, and further research is
warranted.
Dynamic Contrast-Enhanced CT (DCE-CT) uses the same principles as DCEMRI. In DCE-CT, iodinated contrast agents absorb electromagnetic energy via the
photoelectric effect, directly attenuating the x-ray beam. The advantage of DCE-CT is the
linear relationship between contrast concentration and attenuation in CT, which facilitates
quantitative (versus relative) measurement of blood flow and blood volume. The
disadvantages of DCE-CT include the limited coverage, and the use of ionizing radiation
and iodinated contrast agents. In a DCE-CT study of 105 patients with HNSCC treated by
radiotherapy or chemo-radiotherapy with mean follow-up of 2.2 years, patients with a
lower pretreatment perfusion rate had a higher local failure rate [51]. However, in another
study, DCE-CT parameters did not correlate with the hypoxic areas [51]. So the ability of
DCE-CT parameters to reflect tissue hypoxia in HNSCC is still unclear.
1.6 Near-infrared Diffuse Optical Spectroscopy (DOS) for Tissue Oxygenation
Measurements
Diffuse optical spectroscopy (DOS) utilizes light in the near infrared (NIR)
spectral range to quantify the biochemical state of tissues through the measurement of the
absorption and scattering properties of tissues. The NIR window defines the range of
wavelengths from 650 to 900 nm where absorption is relatively low and light has its
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maximum depth of penetration up to several centimeters in tissue. Within the NIR
window, scattering is the most dominant light-tissue interaction, and therefore the
propagating light becomes diffused rapidly. In biological tissue, the primary absorbers of
near-infrared light are deoxygenated hemoglobin, oxygenated hemoglobin, water, and
lipids, and the major source of scattering is the refractive index mismatch between cell
organelles like mitochondria and cytoplasm, and extracellular media and tissue structural
components such as collagen and elastin fibers. When using NIR spectroscopy to detect
optical properties of deep tissues, a pair of source and detector fibers is usually placed
along the tissue surface with a distance of a few millimeters to centimeters. NIR light
generated by a laser emits into tissues through the source fiber and is detected by a
photodetector through the detector fiber. The penetration depth of NIR light in biological
tissues is approximately half of the source-detector (S-D) separation.
The probabilities of absorption and scattering are described by an absorption
coefficient, μa, and a reduced scattering coefficient, μs’, which are also referred to as
optical properties, intrinsic to the probed tissue volume [52, 53]. Changes in
physiological parameters such as tissue oxygenation can be calculated based on tissue
optical properties measured at different wavelengths [54]. Light absorption in tissue is
dependent on the absorption spectra of the major tissue chromophores (Fig. 1.3). In the
NIR region, oxygenated hemoglobin (HbO2) and deoxygenated hemoglobin (Hb) are the
dominant chromophores affecting absorption. Simultaneous measurements at multiple
wavelengths allow to measure the concentrations of oxygenated and deoxygenated
hemoglobin ([HbO2] and [Hb]), total hemoglobin concentration (THC = [HbO2] + [Hb]),
and oxygen saturation (StO2 = [HbO2]/THC).
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Figure 1.3 Absorption spectra of three dominant near-infrared chromophores in tissues,
namely oxygenated-hemoglobin (HbO2), deoxygenated-hemoglobin (Hb), and water
(H2O). The concentrations of Hb and HbO2 are assumed to be 50 μM, a typical value for
blood-perfused tissues. Extinction coefficients for Hb and HbO2 are obtained from [55].
Within the NIR spectral window (650 to 900 nm), light can penetrate tissues deeply due
to the relatively low tissue absorption.

Figure 1.4 Three types of DOS systems including frequency‐domain (FD), time-resolved
(TR), and continuous wave (CW).

DOS devices can be categorized as time-resolved (TR), frequency-domain (FD),
and continuous-wave (CW) systems based on the types of light sources employed (Fig.
1.4) [54]. In TR systems, a very short NIR pulse, usually on the order of picoseconds, is
introduced into the medium, and the delay and spread of the transmitted pulse is
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measured. Because of the need for high-speed detection and high-speed emitters, timeresolved methods are the most expensive and technically complicated method. The FD
systems use amplitude-modulated light at radio-frequency range (e.g. 110 MHz) to
produce a diffusive wave within the medium and the amplitude and phase of the
transmitted diffuse light wave are measured. The TR and FD systems can separate
absorption and scattering effects thus, yielding absolute values of [Hb] and [HbO2]. CW
systems use constant amplitude sources and measure the attenuated light amplitude as a
function of S-D separation and wavelength. CW systems are generally less expensive
than TR and FD systems and provide rapid data collection. However, they lack the
capability of characterizing simultaneously the absorption and scattering coefficients. As
such, CW systems usually assume constant μs’ and provide only information about μa.
1.7 Near-infrared Diffuse Correlation Spectroscopy (DCS) for Tissue Blood Flow
Measurements
DCS [53, 56-58] or diffusing-wave spectroscopy (DWS) [59-63] is an emerging
optical technique that utilizes coherent near-infrared light to non-invasively measure
tissue blood flow. DCS uses a NIR laser with long coherence length (> 5 meters) as the
light source and a single-photon-counting avalanche photodiode (APD) as the detector.
Similar to DOS, the source and detector fibers connected to the laser and APD were
placed on the tissue surface with certain distance (i.e., S-D separation). The light intensity
interference pattern (i.e., speckle pattern) on the tissue surface is detected, which depends
on the motion of moving scatterers in the tissue measured (primarily red blood cells in
microvasculature). By quantifying the changes in speckle pattern, blood flow index (BFI)
can be extracted.
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DCS measurements of deep tissue blood flow have been validated in various
organs and tissues against other standards, including Doppler ultrasound [64-67], XenonCT [68], laser Doppler flowmetry (LDF) [52, 69], fluorescent microsphere flow
measurement [66, 70], and ASL-MRI [71, 72], or through comparisons to literatures [56,
58, 73-75]. The probing depth of NIR DCS (several centimeters) is significantly larger
than those (several millimeters) of similar optical modalities such as LDF [76-78],
Doppler optical coherence tomography (DOCT) [79], and optical micro-angiography
(OMAG) [80]. DCS is primarily sensitive to microvasculature rather than large blood
vessels (e.g., Doppler ultrasound measurement), and does not require radiation exposure.
Systems based on DCS are portable and relatively inexpensive, allowing for bedside
monitoring with short acquisition time (varying from 6.5 ms to several seconds) [74, 8183]. Due to these features, usages of DCS expand continuously into new applications in
various deep organs/tissues such as muscle [72, 82, 84-87], tumor [64, 65, 83, 88-92] and
brain [52, 58, 59, 66-68, 70, 71, 73, 74, 81, 93-97].
1.8 Current Study Limitations
In summary, studies in cancers including head and neck carcinoma have exhibited
an increase of positive response to radiotherapy in tumors with high pretreatment
oxygenation compared to poorly oxygenated tumors [98, 99]. However, in these studies
some well-oxygenated tumors failed to respond, while some hypoxic tumors responded
well, possibly due to changes in tumor oxygenation during radiation therapy. Factors that
modulate tumor oxygenation include blood flow, blood oxygenation, and tumor oxygen
metabolism [18]. Recent PET, MRI and CT investigations have demonstrated significant
tumor blood flow and oxygenation changes during the period of therapy and have
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suggested that these early blood flow variations may have unique prognostic value [3436, 41, 42, 100-102]. Moreover, tumor blood flow level may impact chemotherapy
efficacy since chemo-drug delivery depends on tumor blood flow.
Acute hemodynamic and metabolic changes during radiation delivery may also
affect treatment efficacy since radiation causes acute damage in tumor vasculatures
which may immediately impair blood oxygen supply to the tumor. To exert its sensitizing
effect, oxygen must be present during or within milliseconds after the radiation exposure
delivery of the radiation dose [12]. Moreover, oxygen must also be present in sufficient
quantities to have a radio-sensitizing effect. For example, below a partial pressure of 20
mmHg, cells have significant protection from radiation damage [103]. However, there
have been no reports of monitoring tumor hemodynamics and metabolism during
radiation delivery.
Although many techniques have been used for tumor hemodynamic
measurements, none of them are perfect as reviewed earlier. Near-infrared diffuse optical
instruments provide noninvasive, rapid, portable, and low-cost alternatives for evaluation
of deep tissue hemodynamic parameters. Integration of traditional DOS and DCS into the
same instrumentation creates a new opportunity to make comprehensive assessment of
multiple parameters in the tumor microenvironment including tumor blood flow and
oxygenation. The goal of this study is to adapt and improve some novel diffuse optical
techniques developed in our laboratory for longitudinal evaluation of tumor
hemodynamic responses throughout the time course of treatment (including during
radiation delivery) and to investigate the predictive ability of multiple hemodynamic
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parameters in early prediction of radiation treatment outcomes. Ultimately, such
information will enable clinicians to optimize individual cancer therapies.
1.9 Thesis Organization
This thesis is organized with the following chapters. Chapter 2 introduces the
theory and instrumentation of DOS and DCS technologies. Chapter 3 describes a study
to optimize BFI extraction methods through simultaneously fitting multiple parameters
from one single autocorrelation function in DCS. Chapter 4 presents a study to adapting
a novel DCS flow-oximeter for noninvasive monitoring of tumor hemodynamic changes
during radiation delivery. Chapter 5 reports the continual monitoring of tumor blood
flow and oxygenation over 7 weeks of chemo-radiation therapy using the hybrid
DOS/DCS technique and investigates the prognostic values of hemodynamic
measurements for early predicting treatment responses to radiotherapy. Finally, Chapter
6 summarizes the contributions of this thesis, and discusses the limitations and future
research directions.
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CHAPTER 2 THEORY AND INSTRUMENTATION OF DIFFUSE OPTICAL
TECHNOLOGIES
Several NIR diffuse optical instruments have been recently developed in our
laboratory and used in the studies covered by this dissertation, including a hybrid
DOS/DCS device and a dual-wavelength DCS flow-oximeter. The hybrid device
combining a commercial FD tissue-oximeter (Imagent, ISS, IL, USA) and a custom-built
CW DCS flowmeter allows us to simultaneously measure tumor blood flow and blood
oxygenation [85]. The CW dual-wavelength DCS flow-oximeter can detect the relative
changes of tumor blood flow and blood oxygenation. The dimension/cost of the DCS
flow-oximeter is much smaller/lower than the hybrid DOS/DCS instrument.
2.1 FD and CW DOS Tissue Oximetry
2.1.1 FD Tissue Oximetry
Frequency-domain DOS techniques employ intensity modulated light and
quantify the absorption (μa) and reduced scattering (μs’) coefficients through measuring
the phase shift and amplitude after the diffusive photons propagate through the medium.
The propagation of NIR light in high scattering media such as biological tissues can be
quantified by photon diffusion equation [Appendix I, Eq (2A.10)]. In frequency domain,
analytical solutions of amplitude reduction (Φac) and phase shift (φ) of the detected light
when using an isotropic point source in a semi-infinite homogeneous medium are given
in Appendix I [Eq (2A.22) – Eq (2A.23)], which can be rewritten as linear combinations
of Φac, φ and S-D distance (ρ) [Appendix I, Eq (2A.25) – Eq (2A.26)]. Thus, fitting the
slopes of ln (ρ2 Φac) and φ as a function of ρ (Sac and Sφ respectively) can generate µa and
µs’ (see Eq (2.1) to Eq (2.4)).

16

Sac

vμa 1⁄2
1⁄2
= − ( ) [(1 + x 2 )1⁄2 + 1]
2D

vμa 1⁄2
1⁄2
Sφ = ( ) [(1 + x 2 )1⁄2 − 1]
2D

(2.1)

(2.2)

Here, light source is modulated at a frequency (ω/2π), v is the speed of light in the
medium, D = v/[3(μa+μs’)] is called photon diffusion constant and x is defined as ω/vμa.
Therefore, the values of μa and μs’ can be extracted from the (Sac, Sφ) using the following
equations [104]:
ω Sφ Sac
(
−
)
2v Sac Sφ

(2.3)

v(Sφ 2 − Sac 2 )
− μa
3μa

(2.4)

μa =

μs , =

The tissue absorption depends linearly on the concentrations of tissue
chromophores (primarily HbO2 and Hb). In particular, the absorption coefficient µa at
wavelength λ is given by
μa(λ) = ∑𝑖 𝜀𝑖 (𝜆)𝑐𝑖

(2.5)

Here εi(λ) is the wavelength-dependent extinction coefficient and ci the
concentration of the ith chromophore. Generally, the extinction spectra εi(λ) is known for
typical tissue chromophores and thus the unknown chromophore concentrations ci can be
determined by measuring μa at multiple optical wavelengths.
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Figure 2.1 Extinction coefficients for oxygenated hemoglobin (HbO2) and deoxygenated
hemoglobin (Hb) for near-infrared wavelengths

Frequency-domain DOS diffusion approximation enables us to separate the
scattering and absorption contributions in the detected light signals and to determine the
absolute μa and μs’ at each wavelength. The measured values of μa at two wavelengths
translate Eq (2.5) into a linear system of two equations (one per each wavelength) with
two unknowns ([HbO2] and [Hb]). The solutions in turn give total hemoglobin
concentration (THC = [HbO2] + [Hb]) and blood oxygen saturation (StO2 =
[HbO2]/THC). The two wavelengths λ1 and λ2 for near-infrared oximetry are usually
chosen such that λ1 < λiso < λ2, where λiso (800 nm) is the isosbestic wavelength at which
the extinction coefficients of oxygenated- and deoxygenated-hemoglobin intersect (see
Fig 2.1).

18

2.1.2 CW Tissue Oximetry
CW devices are simpler, faster, less expensive and more compact than FD devices.
However, CW DOS is not inherently able to separate absorption and scattering effects
[105]. Under the assumption that the μs’ remains constant, modified Beer-Lambert law
can be employed to measure relative changes in hemoglobin concentrations (Δ[HbO2]
and Δ[Hb]):
∆𝑂𝐷(𝜆) = − ln

𝐼
= ∑ ∆μ𝑎𝑖 (𝜆) 𝜌𝐷𝑃𝐹(𝜆) = ∑ ɛ𝑖 (𝜆)∆𝑐𝑖 𝜌𝐷𝑃𝐹(𝜆)
𝐼0
𝑖

(2.6)

𝑖

Here OD is the optical density of the medium, I0 and I are the measured intensities
before and after the concentration change, ci is the concentration of the ith chromophore,
ρ is the source-detector distance, and DPF is the differential pathlength factor.
Considering the change in ∆µa resulting from the changes in [HbO2] and [Hb], Eq (2.6)
can be rewritten as:
ΔOD(λ) =(εHbO2 (λ)Δ[HbO2] + εHb (λ)Δ[Hb])𝜌𝐷𝑃𝐹(𝜆)

(2.7)

By measuring ΔOD at two wavelengths and using the known extinction
coefficients of HbO2 and Hb at two wavelengths (λ1 and λ2), we can then determine
relative changes of [HbO2] and [Hb].

∆[𝐻𝑏] =

∆𝑂𝐷 𝜆1
∆𝑂𝐷 𝜆2
𝜆1
−
ɛ
𝐻𝑏𝑂2
𝐷𝑃𝐹 𝜆1
𝐷𝑃𝐹 𝜆2
𝜆1 𝜆2
𝜆2 𝜆1
(ɛ𝐻𝑏
ɛ𝐻𝑏𝑂2 − ɛ𝐻𝑏
ɛ𝐻𝑏𝑂2 )𝜌

𝜆2
ɛ𝐻𝑏𝑂
2

𝜆1
∆𝑂𝐷 𝜆2
𝜆2 ∆𝑂𝐷
−
ɛ
𝐻𝑏
𝜆2
𝐷𝑃𝐹 𝜆1
∆[𝐻𝑏𝑂2 ] = 𝜆1𝐷𝑃𝐹
𝜆2
𝜆2 𝜆1
(ɛ𝐻𝑏 ɛ𝐻𝑏𝑂2 − ɛ𝐻𝑏 ɛ𝐻𝑏𝑂2 )𝜌
𝜆1
ɛ𝐻𝑏
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(2.8)

(2.9)

DPF can be obtained from the literature, or calculated from baseline μs’ and μa
values measured by FD devices (see Appendix III).
2.2 Diffuse Correlation Spectroscopy (DCS)
DCS uses coherent NIR light to penetrate deep tissues and measures speckle
fluctuations of the diffuse light. Most photons scatter multiple times before detection at
some distance from the light source. Each scattering event causes a random scattering
phase shift in the electric field of light and the superposition of multiple light fields with
different phases creates a speckle pattern of interference at the detector. If the scattering
particles move, the speckle pattern fluctuates in time. These fluctuations of the electric
field and intensity carry the dynamical information about the motion of moving
scatterers. In biological tissues, the primary moving scatterers are red blood cells. By
characterizing the fluctuations in speckle intensity over time, we gather information about
blood flow in tissue. Briefly, time dependent light intensity fluctuation can be quantified
by the temporal autocorrelation function. The electric field autocorrelation function is
related to the measured light intensity autocorrelation function through Siegert relation
[106]. It has been found that the electric field autocorrelation function 𝐺1 is governed by a
correlation diffusion equation [56, 57], and blood flow index (BFI) in biological tissues
can be calculated by fitting the measured autocorrelation function curve with the solution
of correlation diffusion equation.
The unnormalized electric field temporal autocorrelation function, 𝐺1 (𝑟⃗, 𝜏) =
〈𝐸⃗⃗ ∗ (𝑟⃗, 𝑡) · 𝐸⃗⃗ (𝑟⃗, 𝑡 + 𝜏)〉 obeys the correlation diffusion equation [56, 57] [Eq (2A.29) in
Appendix II]. For the simple case of a CW point source in a semi-infinite homogeneous
medium, the solution can be obtained as [Eq (2A.32) in Appendix II]:
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vS0 e−𝐾(𝜏)𝑟1 e−𝐾(𝜏)𝑟2
𝐺1 (𝜌, 𝜏) =
(
−
)
4𝜋𝐷
𝑟1
𝑟2
Here,

𝜌

is

the

source-detector
𝑣

separation, r1 = √ρ2 + z0 2 ,

(2.10)

and

𝛼

r2 = √ρ2 + (z0 + 2zb )2 . 𝐾(𝜏) = √𝐷 (μa + 3 μ𝑠 ′ 𝑘02 〈∆𝑟 2 (𝜏)〉) . Scatterers in tissue may
be static (e.g., organelle) or dynamic (moving red blood cells). Therefore, a parameter α
is added to account for not all scatterers being dynamic and is defined as the ratio of
moving scatterers to total scatterers. k0 = 2π/λ is the wavenumber of the CW light in the
medium. 〈∆𝑟 2 (𝜏)〉 is the mean square displacement of a scatterer duing the delay time τ.
2 1+𝑅𝑒𝑓𝑓
s 1−𝑅𝑒𝑓𝑓

z0 ≈ 1/ µs’ and 𝑧𝑏 = 3μ

, where Reff is the effective reflection coefficient to

account for the index mismatch between tissue and air: Reff = -1.44n-2 + 0.71n-1 + 0.668 +
0.064n, and n is the ratio of refraction indices of tissue and air n = ntissue/nair ≃ 1.33. We
get the normalized electric field temporal autocorrelation function from G1:
𝑔1 (𝜌, 𝜏) =

𝐺1 (𝜌, 𝜏)
e−𝐾(𝜏)𝑟1 e−𝐾(𝜏)𝑟2
e−𝐾(0)𝑟1 e−𝐾(0)𝑟2
=(
−
)⁄(
−
)
𝐺1 (𝜌, 0)
𝑟1
𝑟2
𝑟1
𝑟2

(2.11)

In practice, DCS measures the normalized intensity temporal auto-correlation
function, 𝑔2 (𝑟, 𝜏) = 〈I(t) ∙ I(𝑡 + 𝜏)〉⁄〈I(𝑡)〉2 , with the intensity I(t) = |E(t)|2. 𝑔2 (𝑟, 𝜏) is
then related to the normalized electric field temporal autocorrelation function, g1(τ),
through the Siegert relation [106],
g2(τ ) = 1 + β|g1(τ )|2

(2.12)

β is a constant determined primarily by the collection optics of the experiment,
and is equal to one for an ideal experiment setup. The expression of 𝐾(𝜏) suggests that
the decay of the autocorrelation function depends on tissue optical properties µa and µs’,
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the mean-square-displacement of the moving scatterers, 〈∆𝑟 2 (𝜏)〉, and the unitless factor
α. In biological tissues, for the case of diffusive motion,〈∆𝑟 2 (𝜏)〉 = 6𝐷𝐵 𝜏, where DB is
the effective Brownian diffusion coefficient of the moving scatterers and is distinct from
the well-known thermal Brownian diffusion.
v

Substituting 〈∆r 2 (τ)〉 = 6DB τ into K(τ), we get K(τ) = √D (μa + 2αDB μs ′ k 20 τ),
which suggests that the decay of the autocorrelation function depends on µa, µs’, and
αDB . From our previous description, αDB carries information about the dynamic
properties of moving red blood cells in the microvasculature and is defined as a blood
flow index (BFI).
Usually, BFI calculations begin with using the Siegert relationto first determine






the β. Using the g2 data at earliest τ and letting g1 ≈ 1 (i.e., g1 r ,0  G1 r ,0 / G1 r ,0  1 ) lead




to   g 2 ( r ,   0)  1 . Using DCS measured g 2 ( r , ) , calculated β and Siegert relation,

g1 ( r , ) is calculated for all τ. Eq (2.11) is then used with the unknown parameter αDB

(flow index) to fit the g1 derived from DCS measurements. Although the unit of 𝛼𝐷𝐵
(cm2/s) is different from the traditional blood perfusion unit [ml/min/100 g], relative
changes in this blood flow index (𝑟𝐵𝐹 = 𝐵𝐹𝐼/𝐵𝐹𝐼0 ) have been found to correlate quite
well with other blood flow measurement modalities [65, 66, 68, 69, 72] , where 𝐵𝐹𝐼0 is
the baseline flow value measured before the physiological change.
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2.3 DOS/DCS Instruments
2.3.1 FD Tissue Oximeter
In this study a commercial NIR frequency-domain oximeter (Imagent, ISS, IL,
USA) was used which has two channels, each with four sets of four laser sources emitting
light at one of four wavelengths (690, 750, 780 and 830 nm). The four light sources in
each set emit light into tissue through optical fibers placed at four progressively increased
distances (2.0, 2.5, 3.0, and 3.5 cm) from a large fiber bundle (core diameter = 2.5 mm)
connected to a photomultiplier tube (PMT) detector operated in the heterodyne mode.
The lasers are rapidly multiplexed (10 ms) in sequence to allow only one source on at any
point in time. A frequency of 110 MHz is used to modulate the intensity of the light
sources, and a dynode driver at 110.005000 MHz is used to generate a 5-kHz output
signal for phase and intensity measurement. Typically, the measurement time for each
cycle covering all source-detector pairs and wavelengths is 150 ms. Data from several
cycles can be averaged to improve signal-to-noise ratio (SNR) when high sampling rate is
not necessary.
The Imagent uses a heterodyne detection circuit [107, 108] to down-convert the
radio frequency from the 110 MHz signal to the 5 kHz, while retaining the amplitude and
phase information of the detected wave. This low-frequency signal is easily processed by
standard electronic digitization methods. Heterodyne detection allows more accurate
phase and amplitude measurements than homodyne techniques performing amplitude and
phase measurements without down-converting the radio frequency. The Imagent
provides >10 times higher signal-to-noise ratio than the homodyne detection previously
used in hybrid systems developed [92, 109, 110].
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2.3.2 DCS Flowmeter
A DCS flowmeter consists of a CW long-coherence (> 5 m) laser at 785 nm (100
mw, CrystaLaser Inc., NV, USA), 4 single-photon-counting avalanche photodiodes
(APDs) (e.g., Perkin Elmer Inc., Canada), and an autocorrelator board (Correlator.com,
NJ, USA). A fiber-optic probe is usually made using source and detector fibers confined
by a custom-designed soft foam pad. The laser diode delivers light to the tissue through a
multimode source fiber (diameter = 200 µm). One to four single-mode fibers (diameter =
5 µm) connected to the APDs are used to collect speckle intensity variation from a single
(or a few) speckle(s) on the tissue surface. The transistor-transistor logic (TTL) pulses
output from the APD are fed into a correlator board for computing the light intensity [i.e.,
photon count rate with a unit of kilo counts per second (kcps)] and intensity temporal
autocorrelation function [56, 57]. The blood flow index is then extracted from the
autocorrelation function using custom-designed software.

Figure 2.2 A diagram of the multi-tau photon correlator structure

The autocorrelator is based on a multi-tau scheme with a multiple tier structure of
registers to reduce the computational load (Fig. 2.2). The first tier has 32 registers, and
higher tiers have 16 registers each. The first 32 registers of the first tier have a bin width
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T0 (typically 160 ns) and the bin width doubles every 16 registers of the following tiers.
When a measurement starts, the incoming photon count (the number of TTL pulses)
updates the first register within each binning time T0, and the value in each register is
passed to its right as a new value is coming in from the left. From the second tier, the first
register value of nth tier is constructed by sum of the last two register values in (n−1)th
tier, which means the registers of n’th tier is updated every 2n−1T0. Therefore, each
register updates with the corresponding bin width of the register. For each shift that
occurs in the register, the unnormalized intensity autocorrelation coefficient for the ith
register, G2(τi), is calculated as the average value of ni⋅n0, where ni indicates the photon
count in the ith register, n0 is the photon count at zero delay time with the same bin width
as the ith register, and τi is the delay time between ni and n0. Note that n0 is the photon
count in the first register when ni is in the first tier, while n0 is the summation of the
photon count in the first four registers when ni is in the third tier (T/T0=4), etc. With a few
hundred register channels (512 channels for a 31 tier system, for example), a delay time
that ranges from hundreds of nanoseconds to minutes can be achieved, and the
computation load is greatly reduced compared to a linear autocorrelator.
2.3.3 Hybrid DOS/DCS
Previously, Dr. Arjun Yodh’s group at the University of Pennsylvania combined a
custom-made homodyne FD DOS instrument with a DCS device for simultaneous
measurements of tissue blood flow and oxygenation. However, the homodyne instrument
has a relatively low signal-to-noise level and large crosstalk between the detected
amplitude and phase [92, 109, 110]. Our group has initially attempted to combine a
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heterodyne FD Imagent (ISS Inc.) and DCS device to improve the SNRs of tissue
hemodynamic measurements [85, 111].

Figure 2.3 Schematic of hybrid Imagent/DCS instrument for simultaneously measuring
tumor oxygenation and blood flow: (a) hybrid instrument and (b) fiber-optic probe

Figure 2.3 shows the picture and diagram of our hybrid Imagent/DCS instrument.
Computer-controlled TTL signals were used to control the Imagent and DCS devices
working sequentially. A 50 ms delay between the transition of Imagent and DCS
measurements was set to avoid the potential cross-measurement interference. The design
of the hybrid fiber-optic probe was based on the commercial Imagent probe. DCS source
and detector fibers were housed inside the Imagent probe. The optical fibers for the DCS
measurement were arranged in a particular pattern for reducing the interference between
DCS and DOS measurements. Using this hybrid system, we have successfully quantified
blood flow and blood oxygenation in the brain [112], skeletal muscles [85, 113-115], and
head and neck tumors [116]. Since then, several other groups have also built similar
hybrid Imagent/DCS systems for their studies [67, 117, 118].
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2.3.4 Dual-Wavelength DCS Flow-Oximeter
Although the hybrid DCS/DCS systems can effectively quantify both tumor blood
flow and oxygenation, it is relatively expensive, large, and complicated to build and
operate. A portable dual-wavelength CW DCS flow-oximeter was recently developed in
our laboratory, which can simultaneously measure the relative changes in tumor blood
flow and oxygenation from the same region of tissues [85].

Figure 2.4 A diagram of the dual-wavelength DCS Flow-oximeter
Figure 2.4 shows a dual-wavelength 4-channel DCS flow-oximeter. Basically, we
added another long-coherence CW laser at 854 nm to the previous single-wavelength
(785 nm) DCS system. The two lasers were switched on and off alternately by TTL
signals controlled automatically through a custom DCS control panel program. Similarly
to CW DOS, we can extract relative changes of tissue blood oxygenation (i.e., Δ[HbO2],
Δ[Hb], ΔTHC) via measuring light intensity changes at the two wavelengths. The dualwavelength DCS flow-oximeter used two source fibers (core diameter of each fiber = 200
µm, emission area = 0.13 mm2) that were bundled tightly together. The S-D separation
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was set to 2.5 cm for tumor hemodynamic measurement. DCS flow-oximeter shared the
same source and detector fibers for both blood flow and oxygenation measurements, thus
making its probe smaller and easier to be installed on the patients than the hybrid
Imagent/DCS probe.
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Appendix I: Semi-infinite Solution of Photon Diffusion Equation in Frequency
Domain
2.AI.1 Photon Diffusion Equation
Photon transport in biological tissue can be modeled by the radiative transfer
equation (RTE) [119],
1 𝜕𝐿(𝑟⃗, 𝛺̂ , 𝑡)
+ 𝛺̂ ∙ ∇𝐿(𝑟⃗, 𝛺̂ , 𝑡)
v
𝜕𝑡

(2A.1)

= −μ𝑡 𝐿(𝑟⃗, 𝛺̂ , 𝑡) + μ𝑠 ∫4𝜋 𝐿(𝑟⃗, 𝛺̂ ′ , 𝑡)𝑓(𝛺̂ , 𝛺̂ ′ )𝑑 𝛺̂ ′ + 𝑄(𝑟⃗, 𝛺̂ , 𝑡)

.

The light radiance 𝐿(𝑟⃗, 𝛺̂ ′ , 𝑡) is defined as the light power per unit area traveling in the
𝛺̂ direction at position 𝑟⃗ and time t and has units W/(m2 sr). 𝑄(𝑟⃗, 𝛺̂ , 𝑡) (W/(m3 sr)) is the
power per volume emitted by sources at position 𝑟⃗ and time t in the 𝛺̂ direction. 𝑓(𝛺̂ , 𝛺̂ ′ )
is the normalized scattering phase function indicating the probability of scattering a
̂ into the direction ̂
photon that travels along direction Ω
Ω′ , and it satisfies
∫4𝜋 𝑓(𝛺̂ , 𝛺̂ ′ )𝑑 𝛺̂ ′ = 1. The loss of radiance out of each infinitesimal volume element
depends on the transport coefficient μt = μa + μs. Here, the light scattering and absorption
coefficients, µs and µa, are the inverses of the mean free paths for scattering and
absorption, respectively. v is the speed of light in the medium.
A standard approximation method for the RTE is the PN approximation. In this
method, 𝐿(𝑟⃗, 𝛺̂ ′ , 𝑡) in Eq. (2A.1) is written as a series expansion of spherical harmonics
up to Nth order [120]:
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𝑙
𝐿(𝑟⃗, 𝛺̂ , 𝑡) ≈ ∑𝑁
⃗, 𝑡)𝑌𝑙𝑚 (𝛺̂ ).
𝑙=0 ∑𝑚=−𝑙 𝐿𝑙𝑚 (𝑟

(2A.2)

In diffusion theory, radiance is taken to be largely isotropic and the P1
approximation is valid, so only the isotropic and first-order anisotropic terms are
used[121-124]:
1

𝑙

𝐿(𝑟⃗, 𝛺̂ , 𝑡) ≈ ∑ ∑ 𝐿𝑙𝑚 (𝑟⃗, 𝑡)𝑌𝑙𝑚 (𝛺̂ ) =
𝑙=0 𝑚=−𝑙

Here,

𝛷(𝑟⃗, 𝑡) ≡ ∫4𝜋 𝐿(𝑟⃗, 𝛺̂ , 𝑡)𝑑 𝛺̂

is

1
3
𝛷(𝑟⃗, 𝑡) +
𝐽⃗(𝑟⃗, 𝑡) ∙ 𝛺̂
4𝜋
4𝜋

the

photon

fluence

(2A.3)

rate,

and

𝐽⃗(𝑟⃗, 𝑡) ≡ ∫4𝜋 𝐿(𝑟⃗, 𝛺̂ , 𝑡)𝛺̂ 𝑑 𝛺̂ is the photon flux. Similarly the photon source can be
written as:
𝑄(𝑟⃗, 𝛺̂ , 𝑡) ≈

1
3
⃗⃗⃗⃗
𝑆0 (𝑟⃗, 𝑡) +
𝑆 (𝑟⃗, 𝑡) ∙ 𝛺̂
4𝜋
4𝜋 1

(2A.4)

Substituting Eq. (2A.3) and Eq. (2A.4) into Eq. (2A.1), the RTE can be
respectively rewritten in scalar and vector forms as follows:
1 𝜕𝛷(𝑟⃗, 𝑡)
+ ∇ ∙ 𝐽⃗(𝑟⃗, 𝑡) + μ𝑎 𝛷(𝑟⃗, 𝑡) = 𝑆0 (𝑟⃗, 𝑡)
𝑣 𝜕𝑡

(2A.5)

1 𝜕𝐽⃗(𝑟⃗, 𝑡)
1
+ (μ𝑎 + μ′𝑠 ) 𝐽⃗(𝑟⃗, 𝑡) + ∇𝛷(𝑟⃗, 𝑡) = ⃗⃗⃗⃗
𝑆1 (𝑟⃗, 𝑡)
𝑣 𝜕𝑡
3

(2A.6)

This is called the P1 approximation. Here, 𝑆0 (𝑟⃗, 𝑡) ≡ ∫4𝜋 𝑄(𝑟⃗, 𝛺̂ , 𝑡)𝑑 𝛺̂ is the total power
per volume emitted outward from position 𝑟⃗ at time t. μ′𝑠 ≡ μ𝑠 (1 − 𝑔) is called the
reduced scattering coefficient and 𝑔 is anisotropy factor, which is the mean cosine of the
scattering angle, i.e., 𝑔 ≡ ∫4𝜋 𝑓(𝛺̂ , 𝛺̂ ′ )𝛺̂ ∙ 𝛺̂ ′ 𝑑 𝛺̂ ′ . The P1 approximation is quite good
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when μa << μs’, the phase function is not too anisotropic, and the source-detector
separation is large compared to the mean free scattering length 1/ μs’.
To derive the diffusion approximation, we make the assumptions:
⃗⃗⃗⃗
𝑆1 (𝑟⃗, 𝑡) = 0

(2A.7)

1 𝜕|𝐽⃗|
≪ 𝑣(μ𝑎 + μ′𝑠 )
⃗
𝜕𝑡
|𝐽|

(2A.8)

The first assumption is justified for isotropic sources. The second assumption
effectively means that the left-hand-side term in Eq. (2A.8) is taken to be zero. The
implication of the second assumption is best seen in the frequency domain. If the
intensity of the source is sinusoidally modulated with angular frequency ω, the time
dependence of the photon current 𝐽⃗ is thus of the form e−iωt. The time derivatives can be
replaced by multiplying by –iω and the second assumption (when μa << μs’) becomes
ω/(v μs’) << 1. This means that the scattering frequency must be much larger than the
modulation frequency, which is justified for biological tissues when the source
frequencies are less than ∼ 1 GHz [125]. On the other hand, to obtain phase
measurements with good signal-to-noise ratio, the 100 MHz frequency range is the one
typically used for frequency-domain optical studies of biological tissues. With these two
assumptions, Eq (2A.6) simplifies to Fick’s law of diffusion, i.e.,
𝐽⃗(𝑟⃗, 𝑡) = −

1
∇𝛷(𝑟⃗, 𝑡)
3(μ𝑎 + μ′𝑠 )

(2A.9)

Substituting Fick’s law into Eq (2A.5) leads to the time-dependent diffusion
equation[126]:
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∇ ∙ (D(𝑟⃗)∇𝛷(𝑟⃗, 𝑡)) − 𝑣μ𝑎 (𝑟⃗)𝛷(𝑟⃗, 𝑡) −
v
′ (𝑟⃗))
(𝑟
⃗)+μ
𝑎
𝑠

Here D(𝑟⃗) ≡ 3(μ

𝜕𝛷(𝑟⃗, 𝑡)
= −𝑣𝑆0 (𝑟⃗, 𝑡)
𝜕𝑡

(2A.10)

is defined as photon diffusion coefficient. For homogeneous

media,
D∇2 𝛷(𝑟⃗, 𝑡) − vμa 𝛷(𝑟⃗, 𝑡) −

∂𝛷(𝑟⃗, 𝑡)
= −v𝑆0 (𝑟⃗, 𝑡)
∂t

(2A.11)

2.AI.2 Semi-Infinite Solution
We start with the diffusion equation for the fluence rate in a homogeneous
medium (Eq (2A.11)) and assume the point source 𝑆0 (𝑟⃗, 𝑡) and the photon fluence rate
Φ(𝑟⃗, 𝑡) have the general forms:
𝑆0 (𝑟⃗, 𝑡) = 𝑆𝛿(𝑟⃗)[1 + 𝐴]𝑒 −𝑖𝜔𝑡

(2A.12)

Φ(𝑟⃗, 𝑡) = Φ𝑑𝑐 (𝑟⃗) + Φ𝑎𝑐 (𝑟⃗)𝑒 −𝑖(𝜔𝑡−𝜑(𝑟⃗))

(2A.13)

Here 𝛿(𝑟⃗) is Dirac function and φ represents the phase difference between the source and
detected lights.
Substituting Eq (2A.12) and Eq (2A.13) into Eq (2A.11) leads to
vμa
vS𝛿(𝑟⃗)
)Φ𝑑𝑐 (𝑟⃗) = −
𝐷
𝐷

(2A.14)

vμa − 𝑖𝜔
vSA𝑒 −𝑖𝜑(𝑟⃗) 𝛿(𝑟⃗)
] Φ𝑎𝑐 (𝑟⃗) = −
𝐷
𝐷

(2A.15)

(∇2 −

[∇2 −

Eq (2A.14) is the steady-state diffusion equation, and Eq (2A.15) is the frequencydependent diffusion equation.
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When we consider a homogeneous infinite medium, the following results can be
derived from Eq (2A.14) and Eq (2A.15) [127]:
vμa 1⁄2
vS exp[−r ( 𝐷 ) ]
Φ𝑑𝑐 (r) =
4𝜋𝐷
r

Φ𝑎𝑐 (r) =

1⁄2
vμa 1⁄2
2 )1⁄2
exp
{−r
(
)
[(1
+
𝑥
+
1]
}
vSA
2𝐷

4𝜋𝐷

(2A.16)

(2A.17)

r

vμa 1⁄2
1⁄2
𝜑(r) = r ( ) [(1 + 𝑥 2 )1⁄2 − 1]
2𝐷

(2A.18)

Here, r = |𝑟⃗| and x is defined as 𝜔/𝑣μa .

Figure 2.5 Semi-infinite-geometry model. z0 is the depth of the effective isotropic source
inside the biological tissue and zb is the distance between the extrapolated boundary and
the tissue surface. The extrapolated zero boundary condition can be satisfied by
considering a negative isotropic imaging source located at z = -(z0 + 2zb). ρ is the sourcedetector separation on the tissue surface.
In most medical applications of in vivo diffuse optical spectroscopy, both the light
source and the detector are on a tissue surface. Semi-infinite geometry is a particularly
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useful assumption for optical measurements. One simpler boundary condition is a zerocrossing point for the fluence rate at a distance, zb, outside of the tissue [125, 128]:
Φ (z = −zb) = 0
2 1+𝑅𝑒𝑓𝑓

Here, 𝑧𝑏 = 3μ

s

1−𝑅𝑒𝑓𝑓

(2A.19)

, where Reff is the effective reflection coefficient to account for the

index mismatch between tissue and air: Reff = -1.44n-2 + 0.71n-1 + 0.668 + 0.064n and n is
the ratio of refraction indices of tissue and air n= ntissue/nair ≃ 1.33. Eq. (2A.19) is called
the extrapolated-zero boundary condition, which can be satisfied by considering a
negative isotropic imaging source. Because a light beam incident upon the surface can be
well represented by a single scatter source at a depth z0 equal to one effective photon
mean free path (i.e., z0 ≈ 1/ µs’), the negative imaging source is located at –(z0 + 2zb). A
solution for the diffusion equations Eq (2A.14) and Eq (2A.15) in the homogeneous
semi-infinite medium model can be obtained by application of the superposition principle
from Eq (2A.17) – Eq (2A.18):
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Φ = Φ1𝑑𝑐 + Φ1𝑎𝑐 𝑒 −𝑖(𝜔𝑡−𝜑1 ) − Φ2𝑑𝑐 − Φ2𝑎𝑐 𝑒 −𝑖(𝜔𝑡−𝜑2 )
= Φ1𝑑𝑐 − Φ2𝑑𝑐 + (Φ1𝑎𝑐 𝑒 𝑖𝜑1 − Φ2𝑎𝑐 𝑒 𝑖𝜑2 )𝑒 −𝑖𝜔𝑡
vμa 1⁄2
vμa 1⁄2
vS exp[−r1 ( 𝐷 ) ] exp[−r2 ( 𝐷 ) ]
=
(
−
)
4𝜋𝐷
r1
r2
1⁄2
1⁄2
vμa 1⁄2
2 )1⁄2
2 )1⁄2
exp
[−r
(
)
]
{[(1
+
𝑥
+
1]
−
𝑖[(1
+
𝑥
−
1]
}
1
vSA
2𝐷
+
(
4𝜋𝐷
r1

−

1⁄2
1⁄2
vμ 1⁄2
exp [−r2 ( 2𝐷a ) ] {[(1 + 𝑥 2 )1⁄2 + 1] − 𝑖[(1 + 𝑥 2 )1⁄2 − 1] }

r2

(2A.20)

) 𝑒 −𝑖𝜔𝑡

In Fig. 2.5, ρ is the projection of the source detector distance r1 on the interface
plane (z = 0). r1 = √ρ2 + z0 2 , r2 = √ρ2 + (z0 + 2zb )2 . Assuming z0 2 /ρ2 ≪ 1 and
(z0 + 2zb )2 /ρ2 ≪ 1, we can carry over expansions to the second order in (z0 + zb ±zb) /ρ
in Eq. (2A.20) and give the dc and ac photon fluence rate along -z direction and the
phase lag φ between source and detector[104]:
vμa 1⁄2
exp
[−ρ
(
2𝑣 𝑆
vμa 1⁄2
𝐷 ) ]
Φ𝑑𝑐 (ρ) =
[1
+
ρ
(
) ] (𝑧𝑏 + 𝑧0 )
(4𝜋)2 𝐷
ρ3
𝐷
2

× {𝑧𝑏 +

(𝑧𝑏 + 𝑧0 )2 + 3𝑧𝑏 2
3𝐷
[1 −
(3 +
𝑣
2ρ2

vμa 1⁄2 +
exp
[−ρ
(
2𝑣 𝑆𝐴
2𝐷 ) 𝑉 ]
Φ𝑎𝑐 (ρ) =
(4𝜋)2 𝐷
ρ3
2
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2 vμa

(2A.21)

ρ

𝐷
)]}
vμa 1⁄2
1+ ρ( 𝐷 )

(2A.22)

1⁄2

× [1 + ρ (

× 𝑧𝑏 +
{

2vμa
)
𝐷

𝑉 + + ρ2

vμa
(1 +
𝐷

1
1 2
𝑥 2 )2 ] (𝑧𝑏

+ 𝑧0 )

(𝑧𝑏 + 𝑧0 )2 + 3𝑧𝑏 2
3𝐷
1−
𝑣
2ρ2
[
1

vμ 2
1 + ρ ( 2𝐷a ) 𝑉 +
× 2+
1
2vμa 1⁄2 +
2 vμa (1 + 𝑥 2 )2
1
+
ρ
(
)
𝑉
+
ρ
(
𝐷
𝐷
vμa 1⁄2 +
) 𝑉
2𝐷

+ ρ(

)]}

φ(ρ) = ρ (

vμa
)
2𝐷

1⁄2

vμa 1⁄2 −
) 𝑉
2𝐷
𝑉 − − 𝑎𝑟𝑐𝑡𝑎𝑛 (
)
vμa 1⁄2 +
1 + ρ ( 2𝐷 ) 𝑉
ρ(

1/2

Here, 𝑉 + = [(1 + 𝑥 2 )1/2 + 1]

1/2

, 𝑉 − = [(1 + 𝑥 2 )1/2 − 1]

(2A.23)

and as defined previously

x = 𝜔/𝑣μa.
To consider a DOS measurement, Eq (2A.21) – Eq (2A.23) can be rewritten as
following:

ln {

ρ3 Φ𝑑𝑐 (ρ)
vμ 1⁄2
[1 + ρ ( 𝐷a ) ] 𝐹𝑑𝑐 (ρ, μa , 𝐷, 𝑧𝑏 , 𝑧0 , 𝑣)

}

vμa 1⁄2
= − ρ ( ) + 𝐺𝑑𝑐 (𝐷, 𝑆, 𝑧𝑏 , 𝑧0 , 𝑣)
𝐷
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(2A.24)

ρ3 Φ𝑎𝑐 (ρ)

ln
2vμ
[1 + ρ ( 𝐷 a )
{

1⁄2

vμ
𝑉 + + ρ2 𝐷a (1 +

= −ρ(

1
1 2
𝑥 2 )2 ] 𝐹𝑎𝑐 (ρ, μa , 𝐷, 𝑧𝑏 , 𝑧0 , 𝜔, 𝑣)

}

(2A.25)

μa 1⁄2 +
) 𝑉 + 𝐺𝑎𝑐 (𝐷, 𝑆, 𝐴, 𝑧𝑏 , 𝑧0 , 𝑣)
2𝐷
vμa 1⁄2 −
) 𝑉
2𝐷

φ(ρ) + 𝑎𝑟𝑐𝑡𝑎𝑛[𝐹φ (ρ, μa , 𝐷, 𝜔, 𝑣)] = ρ (

(2A.26)

where ρ-dependent functions Fdc, Fad, and Fφ and ρ-independent functions Gdc, and Gac
are defined by Eq (2A.24) – Eq (2A.26). In practice, multiseparation method are used the
quantitive assessment of the absorption (µa) and the reduced scattering (µs’) coefficiens
of tissues by the use of either the (Φac, φ) pair or (Φdc, φ) pair. Because Φac is less
influenced by room light, we usually give µa and µs’ from (Φac, φ) pair. Moreover, the
slope of ln (ρ2 Φac) approximates the slope of the complicated Eq (2A.25) under the the
condition 𝜌√3μ𝑎 μ′𝑠 ≫ 1, which can be satisfied in practical application [129].
Appendix II: Semi-infinite Solution of Correlation Diffusion Equation
In DCS, the temporal autocorrelation function of the total scattered electric field
is used to extract the dynamical information about the medium. Each dynamic light
scattering event contributes to the detected correlation function. Ackerson and coworkers
suggested that it is possible to understand the propagation of temporal autocorrelation in
turbid media primarily by replacing radiance 𝐿(𝑟⃗, 𝛺̂ ′ , 𝑡) in the transport equation [Eq
(2A.1)] with the unnormalized electric field temporal autocorrelation function
𝐺1𝑇 (𝑟⃗, 𝛺̂ ′ , 𝜏) [130].
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∇ ∙ 𝐺1𝑇 (𝑟⃗, 𝛺̂ , 𝜏)𝛺̂ + μ𝑡 𝐺1𝑇 (𝑟⃗, 𝛺̂ , 𝜏) =
(2A.27)
𝑄(𝑟⃗, 𝛺̂ )+ μ𝑠 ∫4𝜋 𝐺1𝑇 (𝑟⃗, 𝛺̂ ′ , 𝜏)𝑔1𝑠 (𝛺̂ , 𝛺̂ ′ , 𝜏)𝑓(𝛺̂ , 𝛺̂ ′ )𝑑 𝛺̂ ′ .
Eq (2A.27) is a steady-state equation applicable for CW sources. Here, 𝐺1𝑇 (𝑟⃗, 𝛺̂ ′ , 𝜏) =
〈𝐸⃗⃗ ∗ (𝑟⃗, 𝛺̂ , 𝑡) · 𝐸⃗⃗ (𝑟⃗, 𝛺̂ , 𝑡 + 𝜏)〉 where 𝐸⃗⃗ (𝑟⃗, 𝛺̂ , 𝑡) is the electric field at position 𝑟⃗ and time t
propagating in the 𝛺̂ direction. 𝑔1𝑠 (𝛺̂ , 𝛺̂ ′ , 𝜏) is the normalized temporal field
autocorrelation function for single scattering and is given by

𝑔1 =

〈𝐸⃗⃗ ∗ (𝑡) · 𝐸⃗⃗ (𝑡 + 𝜏)〉
|𝐸⃗⃗ (𝑡)|

2

1 2
〈∆𝑟 2 (𝜏)〉

= 𝑒 𝑖𝜔𝜏 𝑒 −6𝑞

(2A.28)

Here 〈∆𝑟 2 (𝜏)〉 is the mean square displacement of a scatterer duing the delay time τ, and
𝑞⃗ is the scattered wavevector representing the difference between output and input beam
wavevectors.
After a set of steps identical to the steps used to derive the diffusion equation for
photon fluence rate from the radiative transport equation, we get the correlation diffusion
equation [56, 57],
[∇ · (𝐷(𝑟⃗)∇) − vμa (𝑟⃗) −
Here,

𝛼
𝑣μ ′ 𝑘 2 〈∆𝑟 2 (𝜏)〉] 𝐺1 (𝑟⃗, 𝜏) = −v𝑆0 (𝑟⃗)
3 𝑠 0

𝐺1 (𝑟⃗, 𝜏) = ∫ 𝐺1𝑇 (𝑟⃗, 𝛺̂ , 𝜏)𝑑𝛺̂ = 〈𝐸⃗⃗ ∗ (𝑟⃗, 𝑡) · 𝐸⃗⃗ (𝑟⃗, 𝑡 + 𝜏)〉

is

the

(2A.29)

un-normalized

temporal field autocorrelation function and k0 = 2π/λ is the wavenumber of the CW light
in the medium. Biological tissues contain static scatterers (e.g. organelles, etc.) and
moving scatterers (e.g., red blood cells). The scattering events from the static scatterers
do not contribute to the phase shift. Here we use α (a unitless factor) to represent the
percentage of light scattering events from moving scatterers. For a simple case of a point
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source in a semi-infinite homogeneous medium, the correlation diffusion equation with
the extrapolated zero boundary condition becomes
vμa 𝛼 𝑣 ′ 2
v𝑆0 𝛿(𝑟⃗)
+
μ𝑠 𝑘0 〈∆𝑟 2 (𝜏)〉)] 𝐺1 (𝑟⃗, 𝜏) = −
,
𝐷
3𝐷
𝐷

[∇2 − (

𝐺1 (z =-𝑧𝑏 , τ) = 0.

(2A.30)

(2A.31)

The analytical solution of the correlation diffusion equation will have the same form as
Eq (2A.20),
𝐺1 (𝜌, 𝜏) =

vS0 e−𝐾(𝜏)𝑟1 e−𝐾(𝜏)𝑟2
(
−
)
4𝜋𝐷
𝑟1
𝑟2

(2A.32)

Here, 𝜌 is the source-detector separation, r1 = √ρ2 + z0 2 , and r2 = √ρ2 + (z0 + 2zb )2 .
𝑣

𝛼

𝐾(𝜏) = √𝐷 (μa + 3 μ𝑠 ′ 𝑘02 〈∆𝑟 2 (𝜏)〉) .
Appendix III: Differential Pathlength Factors
In the semi-infinite geometry, an approximation can be made for the dc photon
fluence rate in Eq. (2A.21) [104, 129],
exp(−ρ√3μ′𝑠 μ𝑎 ) 1
Φ𝑑𝑐 (ρ) = C
( + √3μ′𝑠 μ𝑎 )
ρ2
ρ

(2A.33)

where C is a proportionality factor and μs’ is assumed to be constant. Assuming μa =
μa0+Δμa and Δμa/ μa0 << 1, we can get

−ln

Φ𝑑𝑐
√3μ′𝑠 ρ√3μ′𝑠 μ𝑎0
≈ ∆μ𝑎 ∙ ρ ∙
Φ𝑑𝑐0
2√μ𝑎0 1 + ρ√3μ′𝑠 μ𝑎0

which, after comparison with Eq (2.6), gives
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(2A.34)

DPF𝑠𝑒𝑚𝑖𝑖𝑛𝑓 =

√3μ′𝑠

ρ√3μ′𝑠 μ𝑎0

2√μ𝑎0 1 + ρ√3μ′𝑠 μ𝑎0
=

√3μ′𝑠
2√μ𝑎0

(1 −

1
1 + ρ√3μ′𝑠 μ𝑎0

(2A.35)
)

In an infinite turbid medium, DPF can be derived from Eq (2A.16) as follows:

DPF𝑖𝑛𝑓 =

√3μ′𝑠
2√μ𝑎0

(2A.36)

Comparing with Eq (2A.35), we can see that DPFsemiinf increases with source–detector
distance ρ and reaches DPFinf when ρ√3μ′𝑠 μ𝑎0 ≫ 1.
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CHAPTER 3 SIMULTANEOUSLY EXTRACTING MULTIPLE PARAMETERS
VIA FITTING ONE SINGLE AUTOCORRELATION FUNCTION CURVE IN
DCS
3.1 Introduction
To assess individual tumor hemodynamic changes over time or the diversity
between different patients, further improve the accuracy of blood flow index extraction
method is necessary in DCS data analysis. In addition, the measured light intensity
autocorrelation function is determined by not only blood flow, but also tissue optical
properties (i.e., μa and μs’) and a coherence factor β. β relies mainly on light source and
detection optics. It is thus desirable to extract as much information as possible (i.e.,
multiple parameters) from one single autocorrelation function. Some previous studies
have chosen to use the values of μa and μs’ from literature respective to the measured
tissue type (e.g., brain or muscle) for the calculation of DCS blood flow [66, 86]. These
assumptions are susceptible to deviations in tissue optical properties [111]. A few of
recent studies have employed hybrid instruments (DOS and DCS) allowing for
concurrent measurements of both μa and μs’ to extract accurate BFI [67, 83, 88, 131]. In
addition, most previous studies estimated β based on the Siegert relation using the
measured autocorrelation function data at the earliest correlation delay time, and then
fitted BFI (i.e., two-step fitting method) [65, 71, 84, 85, 97]. Although a few recent
studies claimed fitting β and BFI simultaneously [131-133], none of them have compared
the performance of the two methods (i.e., simultaneous fitting versus two-step fitting).
The present study is designed to investigate the possibility of simultaneously
extracting multiple parameters such as μa, μs’, β, and BFI through fitting one single
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autocorrelation function curve and evaluate the performance of different fitting methods.
For this purpose, computer simulations, tissue-like phantom experiments, and in-vivo
tissue measurements were utilized. It is expected that the outcomes from this study will
ultimately improve DCS data analysis.
The work reported in this chapter has been previously published [134] and reprint
permission for this dissertation has been granted by the publisher.
3.2 Methods and Materials
3.2.1 DCS for Flow Measurements
The BFI is quantified by a DCS flowmeter built in our laboratory. Details about
DCS for flow measurements can be found in Section 2.2.
3.2.2 Noise Model for Simulation of Autocorrelation Functions
In order to simulate autocorrelation functions measured in real media, a proper
estimate of measurement noises is needed. Previously, a noise model with single
scattering limit in fluorescence correlation spectroscopy [135] has been adopted for use in
diffuse correlation experiments wherein photons experience multiple scattering events
[75, 81]. The phantom experiments demonstrated that the noise model provided a good
estimate of DCS measurement noises in homogeneous media with infinite geometry.
Briefly, the measured correlation function [g2(τ) – 1] was assumed to decay
approximately exponentially, i.e.,

g2    1   exp    .

The experimental configuration

was characterized by the correlator bin time interval T, bin index m corresponding to the
delay time τ, average number of photons <n> within T [i.e., <n> = I·T, where I was the
detected photon intensity], total averaging time t, and coherence factor β. The noise
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[standard deviation σ(τ)] of the measured correlation function [g2(τ) – 1] at each delay
time τ was estimated to be [81, 135]:
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(3.1)

Accordingly, the signal-noise-ratio (SNR) of DCS measurements at delay time τ was
SNR  

g 2    1

  

, and 1/SNR(τ) can be used to estimate the noise level of DCS

measurements.
For the case of diffuse reflectance measurement on medium surface, a semiinfinite geometry should be considered instead and Eq (2.10) should be used to calculate
[g2(τ) - 1] rather than the assumption of exponential decay function as used in Reference
[81]. However, mathematically it is difficult to derive a noise model based on the
complex Eq (2.10). In the present study, we designed phantom experiments to test the
accuracy of this noise model (Eq (3.1) for use in homogeneous media with semi-infinite
geometry. Tissue-like liquid phantoms were created with Intralipid for control of
scattering (μs’) and particle Brownian motion (αDB), India ink for control of absorption
(μa), and distilled water [111]. Although temperature can affect Brownian motions (αDB)
of Intralipid particles, the room temperature was controlled constant (~23 °C) in order to
obtain stable αDB (flow). Tissue-like liquid phantoms have been commonly used for the
calibration of DCS techniques [56, 58, 111]. The phantom was contained in a glass
aquarium. A fiber-optic probe with a pair of source and detector fibers at a distance of 2.5
cm was secured in contact with the surface of the liquid phantom solution using a
custom-designed holder. We set constant μs′ = 8 cm−1 and vary μa (0.075, 0.100, 0.150
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cm-1) by adding ink to test the noise-model under different levels of noise. Higher μa was
associated with lower number of photons detected (I), thus leading to higher level of
noise [σ(τ)].
After the noise model was verified for semi-infinite geometry, it was used to
generate the normalized intensity autocorrelation curve g2 with noise. An autocorrelation
curve (g2) was firstly generated using Eq (2.10) and Eq (2.12). The standard deviation
σ(τ) of [g2(τ) – 1] was then calculated using Eq (3.1), wherein the β and Γ were obtained
concurrently by fitting the g2 curve with the exponential approximation (the concurrent
fitting method can be found in Section 3.2.4), i.e.,

g 2    1   exp    .

Following a

Gaussian distribution with zero mean and standard deviation σ(τ), noises that varied at
different delay time τ were generated. The simulated noises were then applied on g2(τ) to
create an intensity autocorrelation curve with noise. As indicated in Eq (3.1), the SNR
and noise level (1/SNR) of simulated autocorrelation functions were adjusted by
changing the light intensity or photon count rate (I = <n>/T).
3.2.3 Extraction of Multiple Parameters through Fitting One Single Autocorrelation
Curve
Multiple parameters examined (i.e., αDB, μa, μs’, and β) were extracted by fitting
the measured autocorrelation function curve to the analytical solution of correlation
diffusion equation (Eq (2.10)). The goal was to minimize the sum of squared differences
(SSD) between the measured and calculated autocorrelation functions. The minimization
of the objective function SSD = ∑[g2,m(τ) - g2,c(τ)]2 was done by using Nelder-Mead
simplex algorithm (fminsearch function) in Matlab (Mathwork, Inc., MA), where g2,m(τ)
was the measured intensity autocorrelation function and g2,c(τ) was the analytical model
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of autocorrelation in the semi-infinite reflection geometry (Eq (2.10)). Initial guesses for
these parameters were assigned randomly using the “rand” function in Matlab. The
random variation ranges of these parameters were determined based on the dynamic
ranges in DCS phantom experiments and in-vivo measurements: μa = 0.05 to 0.4 cm-1, μs’
= 2 to 15 cm-1, αDB = 0.4 to 2 × 10-8 cm2/s, and β = 0.1 to 0.9. We set the termination
tolerance for the fitted variables at 10-11, which is ~1000 times smaller than the value of
αDB (0.4 to 2 × 10-8 cm2/s). This termination criterion is strict enough to obtain precise
results for all four parameters.
In order to determine the possibility of fitting μa, μs’ or β along with αDB from
one single autocorrelation curve, we examined the SSD change patterns by varying three
pairs of the four parameters (i.e., μa and αDB, μs’ and αDB, β and αDB), respectively. For
this purpose, a reference light intensity autocorrelation curve without noise, g20, was
initially generated using Eq (2.10) and Eq (2.12) with the given parameters: μa = 0.12
cm-1, μs’ = 8 cm-1, αDB = 10-8 cm2/s, and β = 0.45. The paired parameters were then
varied to generate multiple testing autocorrelation curves. The variation ranges of these
parameters were the same as those indicated above. The SSDs between the testing
autocorrelation curves and the reference autocorrelation curve g20 were calculated and
presented in contour plots as functions of these paired parameters, respectively. Different
SSD patterns (e.g., convergence or divergence) implied the possibility of extracting
multiple parameters from one single autocorrelation curve.
The possibility of extracting multiple parameters was further examined by fitting
the paired parameters simultaneously from the reference autocorrelation curve g20 with
two different levels of noise (I = 100 and 50 kcps). For each noise level, 1000 simulated
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curves were generated and fitted to extract the paired parameters simultaneously. The
discrepancies between the fitted and given values of the paired parameters are expressed
as "percentage errors".
3.2.4 Comparison of Two Methods for Extracting β and αDB
In most previous studies, extracting αDB began with using Eq. (2.12) to determine
β. Using DCS measured g2 data at earliest τ and letting g1 ≈ 1 [i.e.,

g1  ,0  G1  ,0 / G1  ,0  1 ] led to   g2 (  ,  0)  1 . Using g 2 (  , ) , β and Eq
(2.12), g1 (  , ) was calculated for all τ. Equation (2.10) was then used with the
unknown parameter αDB to fit the g1 (  , ) derived from DCS measurements. In addition,
one could also average more g2 datasets (i.e., several data points instead of one single
data point) at early τ to reduce the noise influence for determining β.
During the study of extracting multiple parameters from one single
autocorrelation curve (see Section 3.2.3), we found it possible to simultaneously fit both
β and αDB (see Sections 3.3.1 and 3.3.3). To compare the performance between the two
methods (i.e., two-step fitting versus simultaneously fitting) for extracting β and αDB,
computer simulations, phantom experiments and in-vivo tissue measurements were
utilized. For simulations, the reference autocorrelation curves g20 with noise were
generated based on the procedures described in Section 3.2.2, and the levels of noise
were changed by varying photon count rate from 20 to 500 kcps. At each noise level,
1000 curves were created and fitted by the two methods to examine if they were able to
extract the expected values of β and αDB from the simulated curves.
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The simulation results were further verified with the data collected from the
phantom experiments (see Section 3.2.2) and in-vivo tissue measurements in forearm
flexor muscle. A single-mode detector fiber was placed at a distance of 2.5 cm from the
source fiber for the phantom or tissue measurement. The source and detector fibers were
confined in their positions by a foam pad to form a fiber-optic probe which was placed on
the surface of the measured phantom or tissue. The in-vivo measurement was taken from
one healthy volunteer who signed the informed consent approved by the University of
Kentucky Institutional Review Board. Before the experiment, absolute values of tissue
optical properties (μa and μs’) in forearm flexor muscle were measured by a frequencydomain NIR tissue-oximeter (Imagent, ISS Inc., IL). The measured μa and μs’ were used
as input parameters in calculation of β and αDB with the two methods. To reduce the
influence of physiological variations, the baseline drift of the in-vivo tissue measurement
was removed using a first order high-pass Butterworth filter with a cutoff frequency of
0.05 Hz. For statistical analyses, significances of the difference between the two methods
were tested using a paired t-test. The criterion for significance is p < 0.05.
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3.3 Results
3.3.1 The Noise Model Used in Homogeneous Media with Semi-infinite Geometry

Figure 3.1 Tissue-like phantom experiments to verify the feasibility of applying the noise
model in homogeneous media with semi-infinite geometry. DCS measurements were
performed in three liquid phantoms with different μa (0.075, 0.100, 0.150 cm-1) to test the
noise model under different noise levels. Higher μa was associated with lower number of
photons detected (I), thus leading to higher measurement noise [σ(τ)] and lower signal-tonoise ratio [SNR(τ)]. (a) Comparison of the measurement noises between the measured
autocorrelation curves from the phantoms (dots) and calculated noises predicted by the
noise model (solid curves). The measurement noise decreased as the delay time τ
increased. The “steps” were due to the multi-tau arrangement of the correlator. (b)
Comparison of the SNRs between the measured autocorrelation curves and model
predictions. Although the measurement noise decreased as the delay time τ increased, the
SNR of DCS measurement also decreased because the “signal” dropped even faster than
the noise as τ increased.

Figure 3.1 shows the results from phantom experiments to verify the feasibility of
applying the noise model in homogeneous media with semi-infinite geometry. During the
three titrations of varying μa (0.075, 0.100, 0.150 cm-1) while keeping μs′ constant (8
cm−1), photon counting rates changed correspondingly (66, 41, 20 kcps). 267, 237 and
235 autocorrelation curves were collected sequentially at the three titration steps. The
noise [σ(τ)] (Fig. 3.1a) and SNR (Fig. 3.1b) of the autocorrelation function at each τ
were calculated and plotted (see the dots in Fig. 3.1). The solid curves represent the

48

calculated noises or SNRs using Eq (3.1) with the parameters obtained from the phantom
experiments; β and Γ were obtained simultaneously by fitting the experimental data with
the exponentially decaying function (see Sections 3.2.3 and 3.2.4); the averaging time to
obtain one correlation function curve was kept constant (t = 1 s) for all measurements; the
photon count rates were recorded by the correlator board; the bin time interval T was 121
ns for the first 32 channels and doubled every 16 channels thereafter. As shown in Fig.
3.1, the measurement noise decreased as the delay time τ or light intensity increased,
whereas the SNR increased as the light intensity increased and changed with the variation
of delay time τ. These results are consistent with the predictions from Eq (3.1) and
suggest that the noise model provides a good estimate for DCS noises measured in
homogeneous media with semi-infinite geometry.

Figure 3.2. Comparison of the simulated and measured g2 curves at three different levels
of noise: (a) I = 66 kcps; (b) I = 41 kcps; and (c) I = 20 kcps. The input parameters for
simulation were acquired from the phantom experiments.
We then used this noise model to generate autocorrelation curves (g2) with three
different levels of noise (I = 20, 41, 66 kcps) observed in phantom tests. Figure 3.2 (a, b,
c) shows the results comparing the simulated and measured (from phantoms) g2 curves
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with the same levels of noise. Again, the results demonstrate that the noise model works
well in homogeneous media with semi-infinite geometry.
3.3.2 Extracting Multiple Parameters from One Single Autocorrelation Curve
As indicated in Section 3.2.3, a reference g2 curve without noise was generated
with the given parameters: μa = 0.12 cm-1, μs’ = 8 cm-1, αDB = 10-8 cm2/s, β = 0.45. The
SSDs between the reference curve g20 and the testing curves generated by varying the
values of paired parameters were calculated and presented in Fig. 3.3. The SSD values
were marked on the curves.

Figure 3.3. Contour plots of sum of squared differences (SSD) between a reference
autocorrelation curve g20 obtained with the given parameters [αDB = 10-8 cm2/s, μa (785
nm) = 0.12 cm-1, and μs’ (785 nm) = 8 cm-1] and the testing curves generated by varying
the values of paired parameters. The true reference values of g20 are marked at the cross.
(a) The SSDs obtained by varying μs’ from 2 to 15 cm-1 and αDB from 0.4 to 2 × 10-8
cm2/s. The dashed black curve represents the points at which local minima were achieved
with compositions of μs’ and αDB. (b) The SSDs obtained by varying μa from 0.05 to 0.4
cm-1 and αDB from 0.4 to 2 × 10-8 cm2/s. The dashed black curve illustrates the points at
which local minima were achieved. (c) The SSDs obtained by varying β from 0.1 to 0.9
and αDB from 0.4 to 2 × 10-8 cm2/s. The minimum value of SSD was reached at the true
reference values of β and αDB.
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Different patterns of SSD were observed for different pairs of parameters. The
curves for the pairs of μs’/αDB (Fig. 3.3a) and μa/αDB (Fig. 3.3b) were divergent
although the proportional relationships between the two paired parameters were opposite.
Large crosstalk existed between αDB and μa or αDB and μs’, even if when the SSDs were
close to zero (see the dashed curves in Fig. 3.3a and Fig. 3.3b). Due to the fact that the
SSD was a highly nonlinear function of μa, μs’, β and αDB, the points on the dashed lines
did not have exactly the same SSD value with one another, but the differences among
these values were extremely small. Although the cross (+) point (with the true reference
values) was the absolute minimum, there were numerous local minima along the dashed
line. This made it difficult to obtain the absolute minimum at the cross point because the
searching algorithm could get stuck easily in a local minimum. Conversely, the curves for
the pairs of β and αDB (Fig. 3.3c) were convergent. The minimum value of SSD was
reached at the true reference values of β and αDB (the cross point). In total, these results
suggest that it is possible to fit β and αDB simultaneously and precisely.
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3.3.3 Simultaneously Fitting μa, μs’ or β along with αDB from One Single Autocorrelation
Curve

Figure 3.4 Percentage errors when simultaneously fitting three pairs of four variables
respectively from the simulated autocorrelation curves (g20) generated at two different
levels of noise. The initial guesses of the fitted variables were assigned randomly when
fitting each of the 1000 simulated g20 curves. The discrepancies between the fitted and
given values of the paired parameters are expressed as "% errors”. The upper (a and b)
and lower (c and d) panels represent simulation results with two different levels of noise
(I = 100 and 50 kcps). Higher noise level caused larger evaluation errors. The left panel
(a and c) shows the results when simultaneously fitting αDB and μs’ or αDB and μa. Large
crosstalk between the paired parameters was apparent, resulting in large estimation
errors. The right panel (b and d) shows the results when simultaneously fitting β and αDB.
The estimation errors for both β and αDB were much smaller than those shown in the left
panel (a and c).
The results we got from Section 3.3.2 were further confirmed by simultaneously
fitting the simulated autocorrelation g20 curves with different levels of noise. Figure 3.4
shows the fitting results for extracting the three pairs of parameters simultaneously. The
upper (Fig. 3.4a and Fig. 3.4b) and lower (Fig. 3.4c and Fig. 3.4d) panels represent the
simulation results with two different levels of noise (I = 100 and 50 kcps). As expected,
simultaneously

fitting

μa

and

αDB

may

result

in

estimation

errors;

underestimating/overestimating μa of -60%/+200% led to flow index errors up to -
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100%/+50%. Simultaneously fitting μs’ and αDB may generate even larger errors than
simultaneously fitting μa and αDB; underestimating/overestimating μs’ from -40%/+200%
led to flow index errors up to +120%/-80%. These errors were mainly due to the crosstalk
between the paired parameters. By contrast, when fitting β and αDB simultaneously, the
output values of fitted parameters (β and αDB) clustered around the true values (Fig. 3.4b
and Fig. 3.4d). The estimation errors for both β and αDB at the two noise levels were
smaller than 15%.
3.3.4 Comparison of Two Methods for Extracting β and αDB
The results shown in Sections 3.3.2 and 3.3.3 indicate that β and αDB can be
simultaneously extracted by fitting one single autocorrelation curve. To compare the
performance of the concurrent-fitting method with the conventional two-step fitting
method (i.e., first calculating β and then fitting αDB) for extracting β and αDB, computer
simulations, phantom experiments, and in-vivo tissue measurements were conducted in
the present study.

Figure 3.5 Comparison of the two methods for extracting β and αDB from the simulated
g20 curves under different noise levels (i.e., the photon count rate changes from 500 kcps
to 20 kcps). Dashed lines indicate the expected values (β = 0.45 and αDB = 1 × 10-8
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cm2/s). For both methods, the standard deviation (error bar) of the fitted values increased
with the increase of noise level. Fitting β and αDB simultaneously resulted in unbiased
and more accurate estimation of the means and smaller standard deviations compared to
the two-step fitting method. When estimating β from the first point (a and b), the
standard deviations of β and αDB were large. Estimating β from more points (c and d)
reduced the standard deviations of estimation with the cost of estimation biases in β and
αDB.
Figure 3.5 shows the comparison results from the simulated g20 curves with
different levels of noise (i.e., photon count rate varied from 20 to 500 kcps). For the twostep method, we used either the first data point (upper panel) or averaged seven data
points (lower panel) of g20 at early delay time τ to estimate β. For both concurrent and
two-step fitting methods, the standard deviation of fitted values increased with the
increase of noise level. However, simultaneously fitting β and αDB generated more
accurate values with significantly smaller standard deviations (error bars) compared to
the two-step fitting method (p < 0.001). Inaccurate estimation of β resulted in errors in
fitting αDB, which became more remarkable when the noise level increased. As expected,
using one point to estimate β resulted in large standard deviations of estimation, which
can be reduced by averaging more data points (7 points in this simulation) of g20. Because
of the decay of autocorrelation curve with τ (see Fig. 3.2), however, the averaging led to
significant underestimations of β and αDB (p < 0.001).
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3.3.5 Phantom Experiments and In Vivo Tissue Measurements

Figure 3.6. The performance of the two fitting methods evaluated with the (a) phantom
test and (b) in-vivo measurement. The mean values obtained by the simultaneous fitting
method were assumed as ‘true’ values, and the discrepancies between the values
extracted using the simultaneously fitting method or two-step fitting method are
presented as percentage errors. The error bars are shown with crosses respectively and the
mean values are located at the center of the crosses.
Figure 3.6a shows the estimation deviations of β and αDB from the phantom
experiments described in Section 3.2.2. Notice that only the data from the second step of
titration (μa = 0.10 cm-1) are presented although the results from the other two steps (μa =
0.075 and 0.15 cm-1) were similar. Since the concurrent-fitting method generated accurate
estimates for β and αDB (see simulation results above), the mean values of β and αDB
obtained by this method were assumed to be ‘true’ values of the measured phantom. The
percentage deviations of β and αDB estimated from each autocorrelation curve are
presented as error bars in Fig. 3.6a. Compared to the concurrent-fitting method,
inaccurate estimation of β by the two-step fitting method may result in significant
estimation errors in αDB (p < 0.001) and lead to larger error bars.
Similarly, Fig. 3.6b shows the estimations of β and αDB from the data collected in
in-vivo tissue measurements described in Section 3.2.4. 574 autocorrelation curves were
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collected from the subject’s forearm using the DCS device. The results shown in Fig.
3.6b agreed with those of the simulations shown in Fig. 3.5 and the phantom experiments
shown in Fig. 3.6a.
3.4 Discussion and Conclusions
This study was designed to investigate the possibility of extracting multiple
parameters such as μa, μs’, β, and αDB through fitting one single autocorrelation function
curve and compare the performance of different fitting methods. For this purpose, the
patterns of the sum of squared differences (SSD) between the reference autocorrelation
curve (g20) and the testing autocorrelation curves generated by varying the values of
paired parameters were examined; different SSD patterns (e.g., convergence or
divergence) implied the possibility of extracting multiple parameters from a single
autocorrelation curve. These results were then verified by computer simulations, phantom
experiments and in-vivo tissue measurements.
For simulations with our measurement configuration, a noise model for
homogeneous media with semi-infinite geometry is needed to generate autocorrelation
curves with noise. Previous studies have used a noise model described in Section 3.2.2 as
an approximation [75, 81], which has never been validated in semi-infinite geometry. In
the present study, we designed phantom experiments to test the accuracy of this noise
model for use in homogeneous media with semi-infinite geometry. The phantom
experimental results agreed with the theoretical predictions from the noise model (Fig.
3.1a and Fig. 3.1b) suggesting that it provides a good estimate for DCS noises measured
in homogeneous media with semi-infinite geometry. This noise model was thus used to
generate autocorrelation curves with different levels of noise, and the simulated curves
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were compared with the curves collected from phantom measurements (Fig. 3.2a, Fig.
3.2b and Fig. 3.2c). The comparison results confirmed that this noise model worked well
in homogeneous media with semi-infinite geometry.
To investigate the possibility of fitting μa, μs’ or β along with αDB from one single
autocorrelation curve, we examined the SSD change patterns by varying three pairs of the
four parameters. According to the results, a large crosstalk between the αDB and μa or
αDB and μs’ (Fig. 3.3a and Fig. 3.3b) existed, suggesting that it is impractical to
simultaneously extract αDB and μa or αDB and μs’ from one single autocorrelation curve.
Conversely, the SSD curves for the pairs of β and αDB were convergent, suggesting a
possibility to extract β and αDB simultaneously. These results were then verified by
simultaneously fitting the paired parameters from the simulated autocorrelation curves
with noise generated by the noise model. Fitting αDB and μa or αDB and μs’
simultaneously caused large estimation errors (Fig. 3.4a and Fig. 3.4c) that were majorly
due to the large crosstalk between the paired parameters. These simulation results (Fig.
3.4a and Fig. 3.4c) agree very well with our previous findings in phantom titration tests
(see Fig. 6 in Ref. [111]). By contrast, when fitting β and αDB simultaneously, the
estimation errors for both parameters were much smaller (Fig. 3.4b and Fig. 3.4d),
although they were increased with the increase of noise level.
Upon examination of the K(τ) definition [see Eq. (2.10)], the crosstalk between
αDB and μa or αDB and μs’ is expected as these paired parameters can compensate each
other to generate a similar autocorrelation curve. The decay of an autocorrelation curve is
determined by K(τ) which can be rewritten as:
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is apparent from this expression that the decay of an autocorrelation curve is influenced
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by the term of
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and a variation in αDB can be compensated by a variation in μa or

μs’. By contrast, based on Eq (2.10) and Eq (2.12), β does not affect the decay of the
autocorrelation curve and does not compensate the variation of αDB. Therefore, it is
possible to fit β and αDB simultaneously without causing the crosstalk between them.
We then compared the two methods for extracting β and αDB. All the results from
the simulations (Fig. 3.5), phantom experiments (Fig. 3.6a), and tissue measurements
(Fig. 3.6b) suggested that simultaneously fitting β and αDB from the entire
autocorrelation curve resulted in more accurate values with smaller standard deviations
compared to the two-step fitting method. For the two-step fitting method, large standard
deviations of estimation resulted mainly from the inaccurate β estimated using only
several points at early τ of g2 curve; limited datasets may be contaminated by noises. The
estimation bias was due to the decay of autocorrelation curve with τ, which led to
underestimations of β and αDB.
In conclusion, the possibility of extracting multiple parameters (αDB, μa, μs’ and β)
via fitting one single autocorrelation function curve has not previously been investigated
for DCS measurements. It is not trivial to get the answer regarding such possibility
because the autocorrelation function depends on all four parameters (see Eq (2.10) and
Eq (2.12)) and explicitly expressing the relations among them is difficult. In the present
study, for the first time, we comprehensively investigated the possibility of fitting
multiple parameters from one single autocorrelation curve and evaluated the performance
of the two methods with computer simulations, tissue-like phantom experiments and invivo tissue measurements. The results from this study suggest that it is impractical to
simultaneously fit αDB and μa or αDB and μs’ from one single autocorrelation function
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curve due to the large crosstalk between these paired parameters. However, simultaneous
fitting of β and αDB is feasible and generates more accurate estimation with smaller
standard deviation compared to the conventional two-step fitting method.
The outcomes from this study imply that absolute values of μa and μs’ are needed
for extracting accurate β and αDB. Our laboratory has recently developed a hybrid NIR
diffuse optical instrument combining a commercial frequency-domain tissue-oximeter
and a DCS flowmeter, which allows for simultaneous measurements of μa and μs’ as well
as β and αDB [85]. This hybrid NIR diffuse optical instrument meets the need of absolute
values of μa and μs’ for extracting accurate β and αDB. It is expected that the use of this
type of hybrid instrument and simultaneous fitting algorithms will provide accurate
measurement results.
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CHAPTER 4 DIFFUSE OPTICAL MONITORING OF HEAD AND NECK
TUMOR BLOOD FLOW AND OXYGENATION DURING RADIATION
DELIVERY
4.1 Introduction
As described in Chapter 1, oxygen must be present during or within milliseconds
after the radiation exposure delivery of the radiation dose [12]. Potential instant changes
in tumor hemodynamics during radiation delivery may affect the treatment efficacy. For
example, Yu et al [65] have used a NIR diffuse correlation spectroscopy (DCS) for
noninvasively monitoring tumor blood flow changes during photodynamic therapy
(PDT). They observed a rapid flow decrease in murine tumors during PDT light
illumination, leading to a poor long-term treatment efficacy [65]. With these results, we
want to test the hypothesis that that continuous monitoring of tumor hemodynamics
during radiation delivery may also assist in assessing treatment outcomes.
For this purpose, a customer-designed fiber-optic probe connected to the DCS
flow-oximeter was placed directly on the surface of the radiologically/clinically involved
cervical lymph node. The DCS flow-oximeter, located in the radiation treatment room,
was remotely operated by a computer in the control room. From the early measurements,
abnormal optical signals were observed when the optical device was placed in close
proximity of the primary x-ray beams. Phantom tests were then designed to identify the
source of artifacts. Thereafter, the radiation-generated artifacts were avoided by moving
the optical device away from the primary x-ray beams. With the new experimental setup,
tumor hemodynamic responses to radiation treatment were successfully measured. To the
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best of our knowledge, these are the first noninvasive measurements of tumor
hemodynamic changes during x-ray radiation delivery.
Part of the work reported in this chapter has been previously published [116] and
reprint permission for this dissertation has been granted by the publisher.
4.2. Methods and Materials
4.2.1 Patient Characteristics and Treatment Protocol
Fifty-three patients undergoing chemo-radiation therapy for head and neck tumors
participated in this study with the signed consents approved by the University of
Kentucky Institutional Review Board (IRB). Based on the source-detector (S-D)
separation of 2.5 cm set in our fiber-optic probe (see Section 4.2.2), we included only
Stage III-IVb SCCHN with a cervical tumor node larger than 2 cm detected by
CT/PET/MRI scan or ultrasound machine. Patients with supraclavicular adenopathy were
not enrolled as there was a possibility of the primary origin from other sites in the chest
such as lung or esophagus.
Radiotherapy in combination with traditional chemotherapy was applied on these
patients. Each patient received daily fractional radiation over ~7 weeks. A total dose of 70
Gy was delivered in once daily fractions of 2 Gy. For chemotherapy, the cisplatin was
given at 100 mg/m2 on Day 1 and Day 22 of radiation. The role of chemotherapy
(cisplatin) in head/neck cancer is to increase the incidence of double strand breaks
(radiosensitization) and decrease the incidence of metastatic disease.
During radiation delivery, the patient was immobilized on the treatment table with
pre-molded plastic mask (see Fig. 4.1a and Fig. 4.1b). Radiation was delivered in the
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form of high-energy x-ray beams (6 MV) produced by a medical linear accelerator
(Clinac 21EX, Varian Medical Systems, USA). The X-ray source was mounted on the
end of an L-shaped gantry that can be rotated in a plane 360ºaround the longitudinal axis
of the patient (see Fig. 4.1a). In this configuration, the x-ray source circumscribed a
circle having a radius of 100 cm and always pointed toward the longitudinal patient axis.
This allowed the x-ray beam to be focused to a point in the patient. Seven to nine source
positions were approximately equally spaced over 360ºaround the patient. A typical
treatment required approximately 15 minutes to complete, of which 3 to 4 minutes was
actual radiation delivery. The radiation treatment consisted of a series of several short xray exposures (“beam-on”) followed by periods of no radiation (“beam-off”).

Figure 4.1. A remotely operated DCS flow-oximeter system for monitoring head/neck
tumor hemodynamics during radiation delivery. (a) A DCS flow-oximeter was placed
away from the rotation plane of x-ray beams in the treatment room. (b) A fiber-optic
probe connected with the DCS flow-oximeter was fixed on the surface of cervical tumor
node using a pre-molded plastic mask. (c) A computer in the monitoring/control room
was used to remotely operate the DCS flow-oximeter in the treatment room.
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4.2.2 DCS Flow-Oximeter
Tumor blood flow and oxygenation changes during radiation delivery were
monitored by a DCS flow-oximeter once a week over the 7-week treatment period.
Details about the DCS flow-oximeter (see Fig. 4.1a) can be found in Chapter 2. The
oxygenation information is obtained by recording the light intensities at two wavelengths
(785 and 854 nm) [69, 85, 87, 97]. Δ[HbO2] and Δ[Hb] changes relative to their baseline
values before treatment are calculated using the modified Beer-Lambert Law [136]. The
extinction coefficients are determined based on the literature [137, 138] and DPF values
are calculated using Eq (2A.35).
4.2.3 Remotely-Operated Optical Measurements during Radiation Delivery
A customer-designed fiber-optic probe was taped on the surface of the
radiologically/clinically involved cervical lymph node (see Fig. 4.1b) using Elastikon
tape (Johnson & Johnson Inc., USA) for tumor blood flow and oxygenation
measurements. The optical probe consisted of source and detector fibers (at a separation
of 2.5 cm) whose tips were bent 90ºand held by a soft-foam pad. The nonmetallic optical
fibers and the soft-foam pad are low-density, low atomic number materials which have
negligible attenuation effects on the x-ray beam. A standard head/shoulder plastic
immobilization mask (WFR/Aquaplast Corp., USA) was molded around the prepositioned optical probe to ensure proper probe placement during subsequent treatment
sessions (see Fig. 4.1b). The optical probes and DCS flow-oximeter device were kept
inside the treatment room during radiation delivery and the laptop console was remotely
operated by a computer located in the monitoring/control room (see Fig. 4.1c). The two
computers worked under the “Remote Desktop Connect” mode in the Microsoft

63

Windows Operating System and communicated through the internal network in the clinic.
Using this real-time monitoring system, the optical measurements can be precisely timed
with the presence or absence of the X-ray beam.
From the early optical measurements in some patients, abnormal values of β (>
0.5) and αDB were observed for some X-ray beam positions. The occurrence of the
artifacts depended on the angle of the X-ray beams as well as the location of optical
device. We suspect that scattered X-rays were interacting directly with the photodiodes
generating spurious signals. These signal perturbations were apparently responsible for
the measurement artifacts in autocorrelation functions. To confirm the source of these
artifacts, phantom tests were performed (see Section 4.2.4) under the same radiation
conditions used for the patient treatments.
4.2.4 Phantom Tests to Identify Optical Measurement Artifacts
Tissue-like liquid phantoms have been commonly used for instrument calibration
and experimental validation of DCS techniques [58, 111, 139, 140]. For this study, the
experimental phantom was prepared by filling a cylindrical tank with the mixture of
distilled water, India ink (Black India 44201, Higgins, USA) and Intralipid (Fresenius
Kabi, Sweden). India ink was used to determine the absorption coefficient µa while
Intralipid provided particle Brownian motion (flow) and control of the reduced scattering
coefficient µs’. We set µa = 0.12 cm-1 and µs’ = 8 cm-1 at 785 nm to mimic the property of
real tissues [111]. The Intralipid phantom provided a homogeneous tissue model with
controlled optical properties and constant particle flow, which should not be changed by
the x rays. In addition, using tissue phantom can avoid some other potential artifacts (e.g.,
motion artifacts) that may occur in the patient measurements [86].
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The set up for the phantom test was similar to that for patient measurements
shown in Fig. 4.1, except that the patient was replaced with the liquid phantom contained
by a cylindrical tank. During the beam-on interval, the x-ray beam was turned on
continually and rotated around the liquid phantom over 360 degrees. The fiber-optic
probe was secured in contact with the phantom surface using a customer-designed holder.
The DCS flow-oximeter device was set up in two locations inside the treatment room;
one was close to the x-ray beam plane so that the optical device was subjected to a
significant fluence of scattered x rays and another was several meters away from the xray beam plane. This arrangement approximated the two extreme positions in a typical
patient treatment delivery. The radiation beam energy (6 MV) used for the phantom tests
was same for the patient treatments (see Section 4.2.3).
4.2.5 Data Analysis
Patients were classified into two groups based on clinical outcomes: a complete
response (CR) group and an incomplete response (IR) group with remote metastasis
and/or local recurrence within one year. Although 53 patients were measured, 40 patients
with one-year follow-up results are included in data analysis, among which 12 patient
data were excluded for data analysis as their optical measurements thought to be
contaminated by scattered x rays, one patient withdrew from this study at request of the
patient and one patient was not willing to undergo measurements during radiation
delivery. The data exclusion of the 12 patients was based on the abnormal β value (> 0.5).
Details about the tumors, optical measurements (without artifacts), and treatment
outcomes of the 26 patients are listed in Table 4.1. Patients with unknown primary
cancers (#18 and #20) were treated as head/neck cancers based on nodal stage of disease
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with primary origin suspected in the tonsil or the base of tongue. The Response
Evaluation Criteria in Solid Tumors (RECIST) [141] were used to define the tumor
response to chemo-radiation therapy. The optical measurements over the entire treatment
course were not always available for each individual due to the patient related events
such as side effects of treatment, fatigue, non-compliance with chemo-radiation regimen
or due to time constraints of obtaining measurements and modification of treatment
schedules as a consequence of temporary breakdown in radiation therapy equipment.
Table 4.1 Characteristics of patients/tumors, optical measurements, and treatment
outcomes
Pat.
No

Primary

TNM

Age

Sex

Tumor node
3

site

volume(cm )

p16

Data

Data

Treatment

status

availability

availability

outcome

(during-

(pre-

treatment)

treatment)

1

Tonsil

T3N2cM0

64

M

68.36

positive

E

A

CR

2

BOT

T3N2cM0

63

F

2.97

negative

E

A

IR

3

Tonsil

T1N3M0

52

M

94.08

positive

E

A

CR

4

Pyriform
Sinus

T3N2cM0

54

M

70.31

negative

E

A

IR

5

Tonsil

T3N2bM0

69

M

10.21

positive

E

A

IR

6

BOT

T4aN2cM0

72

M

17.40

positive

E

A

CR

7

Tonsil

T3N2bM0

67

M

10.80

NA

E

A

CR

8

Tonsil

T0N2bM0

41

M

29.65

NA

E

A

CR

9

Tonsil

T4aN2cM0

58

M

37.20

positive

E

A

IR

10

BOT

T4aN2cM0

59

M

3.54

positive

E

A

CR

11

BOT

T4aN2bM0

62

F

1.25

negative

E

NA

CR

66

12

Tonsil

T2N2cM0

69

M

32.60

positive

E

NA

CR

13

Tonsil

T2N2cM0

67

M

34.00

negative

A

NA

IR

14

BOT

T3N2cM0

64

M

57.90

positive

A

NA

IR

15

BOT

T1N2bM0

67

M

27.00

positive

A

NA

CR

16

BOT

T2N2cM0

62

M

90.00

positive

A

A

IR

17

Tonsil

T1N2bM0

58

M

24.00

positive

A

A

CR

18

Unknown

TxN3M0

67

M

18.00

negative

A

A

CR

19

BOT

T2N2cM0

53

M

28.00

positive

A

A

CR

20

Unknown

TxN2bM0

53

M

14.60

NA

A

A

CR

21

Larynx

T4aN2aM0

66

M

44.10

negative

A

A

CR

22

BOT

T3N2cM0

74

M

14.00

negative

A

A

CR

23

Larynx

T3N2cM0

55

M

16.00

negative

A

A

CR

24

Tonsil

T4aN2cM0

50

M

75.60

positive

A

A

IR

25

Tonsil

T4aN2cM0

70

M

51.40

positive

A

A

IR

26

BOT

T4aN2cM0

60

M

80.14

negative

A

A

CR

27

Larynx

T4aN2cM0

60

F

13.68

positive

A

A

CR

Tonsil

T3N2bM0

48

M

18.56

positive

A

A

CR

29

BOT

T3N2bM0

56

M

17.61

positive

NA

NA

IR

30

Tonsil

T1N2bM0

58

M

96.00

positive

A

A

CR

31

BOT

T0N2bM0

51

F

7.20

NA

A

A

CR

32

Tonsil

T4aN2bM0

59

M

70.10

positive

A

A

CR

33

BOT

T4aN2bM0

60

M

38.10

positive

A

A

CR

34

Larynx

T3N2cM0

49

M

65.30

negative

A

A

CR

35

BOT

T2N2bM0

63

M

35.20

positive

A

A

IR

36

Larynx

T1N2cM0

63

F

4.51

negative

A

A

IR

28

67

37

Tonsil

T3N3M0

50

M

221.90

positive

NA

A

IR

38

Larynx

T3N2cM0

51

F

38.88

negative

A

A

IR

39

Larynx

T2N2cM0

55

M

19.66

negative

A

A

CR

40

Tonsil

T4aN2cM0

58

M

127.92

positive

A

A

CR

Abbreviations: Pat. = Patient, M: male, F: female, BOT = Base of Tongue, TNM = Tumor, Node, and Metastasis stage, A = Data
Available, E = Data Excluded (data contaminated by artifacts), NA = Data Not Available, CR = Complete Response, IR = Incomplete
Response

Since DCS flow signals are not sensitive to variation in the wavelength [85, 111],
blood flow data obtained from one wavelength (785 nm) are presented in this study. The
time courses of blood flow and oxygenation data are normalized to their baseline values
right before the radiation delivery, respectively. More specifically, rBF represents the
blood flow change relative to its baseline (assigned to be “1”), and the Δ[HbO2] and
Δ[Hb] are the dynamic changes in oxygenated and deoxygenated hemoglobin
concentrations relative to their baselines (assigned to be “0”). The rBF, Δ[HbO2] and
Δ[Hb] during the fractional radiation deliveries (beam-on intervals) or between the
fractional deliveries (beam-off intervals) are averaged separately for assessing the instant
response to radiation delivery in each individual. The averaged hemodynamic changes
over patients at multiple weeks generate the dynamic variation trends of rBF, Δ[HbO2]
and Δ[Hb] over the treatment period. The average hemodynamic responses over subjects
are presented as means ± standard errors (error bars) in figures. For statistical analyses,
significance is tested using the paired t-test. The criterion for significance is p < 0.05.
To compare the longitudinal tumor hemodynamic responses between the CR and
IR groups, we used linear mixed models [142] with fixed effects of time (as categorical),
CR/IR group, and their interaction and banded covariance structures. Based on the linear
mixed model for each hemodynamic parameter, an overall test was first constructed to

68

assess whether there were differences in that parameter between the CR and IR groups at
any time point. In the case of a significant overall test, post hoc pairwise comparisons
were then conducted at each time point and the Holm's procedure was used to adjust for
multiple comparisons. A p value less than 0.05 was considered significant.
4.3. Results
4.3.1 Phantom Tests
Figure 4.2 shows the optical measurement data at the wavelength of 785 nm from
the phantom test when the DCS flow-oximeter was placed close to the x-ray beam plane.
During the test, the x-ray beam was rotated around the liquid phantom over 360 degrees.
When the x-ray beam was directed toward the optical device, abnormal correlation curves
(g2) were obtained (see an example shown in Fig. 4.2a) leading to large increases in β (>
0.5, see Fig. 4.2b) and αDB (see Fig. 4.2c) as well as slight increases in detected photon
count rate (see Fig. 4.2d). When the DCS flow-oximeter device was moved away from
the rotation plane of the x-ray beams, the optical measurements became normal for all
beam directions. Similar results at the wavelength of 854 nm were also found during the
phantom test (data are not shown). Notice that in this study β (Fig. 4.2b) and αDB (Fig.
4.2c) were derived by fitting the measured autocorrelation function curve g2 (Fig. 4.2a),
as mentioned in Section 4.2.2. However, β can be also estimated based on the Siegert
relation using the measured g2 data (Fig. 4.2a) at earliest τ and letting the normalized
autocorrelation function g1 ≈ 1, i.e., β = g2(τ ≈ 0) - 1 (Fig. 4.2b) [111].
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Figure 4.2 The phantom test results to verify the source of optical measurement artifacts.
(a) Two autocorrelation curves (g2) were collected at the time points of 117
(contaminated) and 55 (not contaminated) (sec), respectively. The measured
autocorrelation curve (empty circles) was contaminated by scattered x rays, resulting in
an abnormal increase in β. (b) The appearance of abnormal increases in β (> 0.5, empty
circles) depended on the direction/angle of the radiation beam that rotated 360°around
the phantom. (c) The x-ray beam induced abnormal increases in relative flow (empty
circles) derived from the autocorrelation curves. (d) The x-ray beam induced slight
increases in detected photon count rate (×103 photons/s) (empty circles).

Figure 4.3 The in vivo measurement results for the investigation of optical measurement
artifacts induced by scattered x rays. (a) Three autocorrelation curves (g2) were collected
at the time points of 417 (contaminated), 99 (slow flow), and 724 (fast flow) (sec),
respectively. Similar to the phantom test results (see Fig. 4.2a), scattered x-rays
contaminated the measured autocorrelation curves (empty circles). For the data without
contaminations (solid circles), the decay rate of autocorrelation curves depended on the
level of blood flow; g2 decayed faster when blood flow was faster (black solid circles).
As expected, β (can be estimated using the measured g2 data at earliest τ) was
independent of blood flow changes when there were no x-ray induced artifacts. (b)
Scattered x rays created abnormal increases in β (> 0.5, empty circles) depending on the
direction/angle of radiation beam. (c) The x-ray beam introduced abnormal increases in
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blood flow (empty circles) derived from the autocorrelation curves. (d) The x-ray beam
induced minor variations in detected photon count rate (×103 photons/s) (empty circles).
4.3.2 In Vivo Optical Measurements
Artifacts were also observed in some optical measurements of tumor
hemodynamics for some x-ray beam directions. Figure 4.3 shows the typical
contaminated optical data measured at the wavelength of 785 nm during a fractional
radiation treatment. Similar to the phantom test results, abnormal correlation curves as
well as the increases in β (> 0.5) and blood flow index (αDB) were observed (see Fig.
4.3a, 4.3b, and 4.3c) when the optical device was subjected to significantly scattered x
rays. This effect also induced minor variations in detected photon count rate (see Fig.
4.3d). Similar artifacts were also observed at the wavelength of 854 nm (data are not
shown). These results are consistent with the findings from the phantom tests (see Section
4.3.1).
After identifying the source of radiation artifacts, we modified the optical
measurements to minimize these effects. A new fiber-optic probe was constructed using
the source and detector fibers with a length longer than 5 meters. The optical device
connected with the new probe was placed approximately 3 meters from the rotation plane
of the x-ray beams. The longer fiber cable allowed the DCS detector assembly to be
moved much further away from the primary beam plane so that the impact of scattered x
rays on the detector was minimized. Thereafter, using the new measurement
configuration no artifacts (i.e., abnormal β and αDB) were observed in the optical data.
Figure 4.4 shows the typical responses of rBF, Δ[Hb] and Δ[HbO2] during radiation
delivery measured from one patient (#18) at two different weeks (Week 1 and Week 4).
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The values of β throughout the treatment period were stable and approximately equal to
0.5 (see Fig. 4.4a and Fig. 4.4b), indicating no artifacts involved in the optical
measurements. A gradual increase in rBF was observed at Week 1 (see Fig. 4.4c), but not
at Week 4 (see Fig. 4.4d). Variations in Δ[Hb] (see Fig. 4.4e and Fig. 4.4f) and Δ[HbO2]
(see Fig. 4.4g and Fig. 4.4h) were also found at both weeks. There were no obvious
differences in tumor hemodynamic responses (i.e., rBF, Δ[Hb] and Δ[HbO2]) between the
intervals of x-ray beam-on and beam-off.

Figure 4.4. The in vivo optical measurement results without x-ray induced
artifacts during radiation delivery from one patient (#6) at Week 1 (left panel) and
Week 4 (right panel). As expected, β ((a) and (b)) was stable throughout the
fractional radiation deliveries and independent of blood flow changes. The typical
responses of rBF ((c) and (d)), Δ[Hb] ((e) and (f)), and Δ[HbO2] ((g) and (h))
were continuously monitored by the DCS flow-oximeter during radiation delivery.

4.3.3 Averaged Hemodynamic Responses over Patients
In this section, our published results based on 11 patients (#13-#23) are firstly
presented, followed by updated data resulting from the total 26 patients. Figure 4.5
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shows the averaged dynamic changes in rBF, Δ[Hb], and Δ[HbO2] over the 11 patients at
different weeks. The numbers of patients with valid optical data (without artifacts) are
labeled at each week in Fig. 4.5a. On average, there were no significant differences in
most of the measured hemodynamic variables (i.e., rBF, Δ[Hb], Δ[HbO2]) between the
intervals of x-ray beam-on and beam-off, except that a small but significant difference in
Δ[HbO2] (-0.29 ± 0.12 µM, p = 0.03) was observed between the x-ray beam-on and
beam-off at Week 1 (see Fig. 4.5c). However, the changes in Δ[HbO2] during radiation
delivery at Week 1 for both beam-on and beam-off were insignificant compared to their
baseline values, respectively. As a result, the averaged ΔHbO2 changes including both
beam-on and beam-off data at Week 1 were also insignificant. Therefore, the
hemodynamic changes were believed to be induced by an accumulated effect of the
fractional radiation dose over the entire period of radiation delivery. Thus, we calculated
the individual means of hemodynamic responses (i.e., rBF, Δ[Hb] and Δ[HbO2]) over the
entire course of radiation treatment including both beam-on and beam-off intervals. The
calculated average hemodynamic results over the 11 patients are listed in Table 4.2.
Although variations in rBF during radiation delivery were observed over the 7-week
treatment period, only the change at the first week (1.11 ± 0.03) were significant (p =
0.003) compared to its baseline before treatment. By contrast, the variations in both
Δ[Hb] and Δ[HbO2] over the treatment periods were not statistically significant.
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Figure 4.5. The averaged dynamic changes in rBF (a), Δ[Hb] (b) and Δ[HbO2] (c)
over the 11 patients at different weeks. Data obtained during the fractional
radiation deliveries (beam-on intervals) or between the fractional deliveries
(beam-off intervals) were averaged separately. A small but significant difference
in Δ[HbO2] (-0.29 ± 0.12 µM) was observed between the x-ray beam-on and
beam-off at Week 1 (* represents p < 0.05).

Table 4.2 Overall changes (means ±standard errors) in rBF, Δ[Hb] and Δ[HbO2] over 11
patients at different weeks
Week
1
2
3
4
5
6
7
Number of patients
11
9
5
5
3
5
4
1.05
1.06
1.11 ± 1.04 ± 1.07 ± 1.03 ± 1.13 ±
rBF
±
±
0.03**
0.03
0.06
0.05
0.12
0.04
0.04
0.71 -0.21
-0.96 ± 0.91 ± 1.82 ± 1.77 ± 0.05 ±
Δ[Hb] (µM)
±
±
1.66
1.00
0.58
0.97
1.10
0.92
1.02
1.66
1.46
-0.44 ± 0.00 ± -0.36
-0.97 0.67 ±
Δ[HbO2] (µM)
±
±
0.70
0.69
±1.07 ±0.87
0.54
0.85
2.14
∗∗ represents p < 0.01.
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Figure 4.6 Averaged values (means ± standard errors) of rBF, Δ[Hb] and Δ[HbO2] in 26
patients at different weeks. Overall changes in 26 patients (left panel, (a), (c), (e)) and
changes in patients grouped by incomplete response (IR) and complete response
(CR)graoup (right panel, (b), (d), (f)). The numbers shown at each week represent the
valid measurements in all patients, respectively. ∗ represents p < 0.05 and ∗∗ represents p
< 0.01.

Figure 4.6 shows the updated results of the 26 patients. Overall on average (n =
26, see the left panel in Fig. 4.6), we observed significant changes in rBF at the first two
weeks (1.13 ± 0.03 and 1.10 ± 0.04; p = 0.0006 and 0.03) compared to its baseline values
before the treatment. Only the changes in Δ[Hb] at the Week 3 (1.18 ± 0.40 µM) were
significant (p = 0.01) compared to its baseline value before the treatment.
However, after breaking down the patients into subgroups of CR and IR groups
and testing global difference with linear mixed model, no overall significant difference
was found in rBF, Δ[Hb] and Δ[HbO2] (p = 0.17, 0.55 and 0.41 respectively) between
these two group (right panel in Fig. 4.6).
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4.4. Discussion and Conclusions
Although NIR diffuse optical techniques have been used as bedside monitoring
tools in many clinical studies [65, 83, 88, 91, 143-153], they have not been applied to
patients inside radiation treatment room. The challenges to adapt the optical techniques
for use during radiation delivery include installing the optical probe properly on the
surface of tumor node, operating the optical device from a separated control room, and
avoiding the potential interference between the scattered X rays and optical
measurements.
In the present study several crucial steps were taken to adapt the DCS flowoximeter for the use of monitoring tumor blood flow and oxygenation during radiation
delivery. A pre-molded plastic mask was made to hold the optical probe in a proper
contact with the tumor nodal mass (see Fig. 4.1a and Fig. 4.1b) throughout the treatment
period for reducing the motion artifacts to optical measurements. Two computers located
separately in the treatment and control rooms communicated through the internal
network, enabling to remotely operate the DCS flow-oximeter (see Fig. 4.1c). Finally,
tissue phantom tests were conducted to determine the source of optical measurement
artifacts (i.e., abnormal β and αDB) observed in the patient measurements during radiation
delivery.
As described early in Section 3.2.2, β depends mainly on the detection optics, and
the maximum β value should be ∼0.5 when using a single-mode fiber to detect the
speckle fluctuations [140]. However, abnormal high values of β (> 0.5) were observed
during radiation delivery in both phantom (see Fig. 4.2) and patient (see Fig. 4.3)
measurements when the optical device was placed close to the rotation plane of x-ray
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beams. When the DCS flow-oximeter device was moved away from the x-ray beams, the
optical measurements became normal throughout the entire treatment period (see Fig.
4.4). These findings suggest that the observed artifacts were generated by the scattered X
rays interacting directly with the optical detector and they can be eliminated by simply
moving the optical device (detector) away from the radiation beams.
After moving the optical device out of the X-ray beams, we have successfully
collected valid optical data (without artifacts) from 26 patients during x-ray delivery.
Large inter-patient variations in tumor hemodynamic responses were observed during
radiation delivery (see the large error bars in Fig. 4.5). On average (see Table 4.2 and
Fig. 4.6), a significant increase in tumor blood flow during radiation delivery was
observed at the first two weeks of treatment, which may be a physiologic response to
hypoxia created by radiation oxygen consumption. Similar increases in blood flow were
previously observed in tumors during the early period of PDT delivery [65]. This
regulation ability in blood flow seemed to decline with the progress of weekly treatments.
Interestingly, only small and insignificant changes were found in tumor blood
oxygenation (Δ[Hb] and Δ[HbO2]) during radiation delivery over the 7-week treatment
period (see Table 4.2). The absence of substantial tumor oxygenation changes suggested
that oxygen utilizations in tumors during the short period of fractional radiation deliveries
(3 to 4 minutes) were either minimal or balanced by other effects such as blood flow
regulation.
The increase in rBF can reduce the tumor [Hb] level at the first two weeks but
with treatment progress, the loss of blood flow regulation ability leads to an increase
trend in Δ[Hb] and a decrease trend in Δ[HbO2]. Clarification of the reasons for limited
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oxygenation changes during radiation delivery will require separate investigations.
Oxygenation changes during radiation therapy may be due to the reassortment of the cells
in the cell cycle, revascularization, repopulation of the tumor cells and cell kill. As these
issues were not being measured it is outside the purview of the present study.
No overall significant difference was found in rBF, Δ[Hb] and Δ[HbO2] between
CR and IR groups (right panel in Fig. 4.6), suggesting insignificant influences of these
factors on measurement/treatment outcomes with small variations of these parameters in
very short treatment time.
Although there is much work to be done, our pilot study results suggest that tumor
hemodynamic changes during radiation delivery can be optically detected using the DCS
flow-oximeter without being overly burdensome on patients. The unique remotely
operated optical system developed in this study has potential to be used in other
therapeutic/diagnostic rooms (e.g., CT) where operators are not allowed to stay.
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CHAPTER 5 DIFFUSE OPTICAL MEASUREMENTS OF HEAD AND NECK
TUMOR HEMODYNAMICS FOR EARLY PREDICTION OF CHEMORADIATION THERAPY OUTCOMES
5.1 Introduction
Near-infrared (NIR) diffuse optical methods offer a noninvasive, portable, fast,
and low-cost alternative for frequently monitoring tumor microvascular hemodynamics at
the bedside over the time course of treatment [65, 83, 88, 91, 143-153]. For example,
Sunar et al previously used a hybrid NIR diffuse optical instrument for noninvasive
measurements of tumor hemodynamic responses to chemo-radiation therapy in a small
group of patients with head and neck tumor [88]. Tumors exhibited significant flow and
oxygenation changes during the first four weeks of the treatment. However, their study
was limited by the small number of patients examined (n = 8) and only one patient out of
8 showed a partial response to the treatment. It was therefore difficult to draw a
conclusion from this pilot study about the feasibility of measuring tumor hemodynamics
for predicting treatment outcomes [88].
Our study aimed to investigate prognostic values of hemodynamic measurements
in head and neck tumors during chemo-radiation therapy for predicting treatment
responses. For this purpose, we developed a novel hybrid diffuse optical instrument
combining a commercial frequency-domain tissue oximeter (Imagent, ISS Inc., IL) and a
custom-made diffuse correlation spectroscopy (DCS) flowmeter, which allowed for
simultaneous measurements of tumor blood flow and blood oxygenation [85, 111, 134].
The clinically involved cervical lymph nodes were measured by this hybrid instrument
once a week over the treatment period of 7 weeks. A linear mixed model was then

79

applied to investigate the sensitivity and specificity using early tumor hemodynamic
responses to therapy to predict one-year treatment outcomes.
5.2 Methods and Materials
5.2.1. A Hybrid Diffuse Optical Instrument for Continually Monitoring Tumor
Hemodynamics
Our hybrid diffuse optical instrument combining a commercial NIR tissueoximeter (Imagent, ISS, IL) and a custom-built DCS flowmeter allows us to measure
simultaneously tumor blood flow and blood oxygenation (Fig. 2.3). For this study, we
built a hybrid fiber-optic probe by adding the source and detector fibers for DCS
measurement onto the Imagent probe (Fig. 2.3b). As mentioned earlier, the S-D distances
for DCS and Imagent were 2.5 cm and 2.0 to 3.5 cm respectively, allowing for the
detection of a tumor larger than 2 cm in size. Computer-controlled transistor-transistor
logic (TTL) signals were used to control the Imagent and DCS devices working
alternately; lasers for DCS and Imagent measurements were turned on sequentially to
avoid the light interference between the two measurements (Fig. 2.3a). The sampling
time for a complete frame of blood flow and oxygen measurements was ~4 seconds (0.
25 Hz).
Our previous investigations have revealed that µa and µs’ can significantly affect
the accuracy of DCS flow quantifications [111, 134]. Thus, μa and μs’ measured by the
Imagent at 780 nm (close to the 785 nm laser used for DCS flow measurements) were
used as inputs for calculating BFI (see Fig. 2.3a). The final outputs from this hybrid
instrument included µa, µs’, [HbO2], [Hb], THC, StO2, and BFI.
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5.2.2. Patient Characteristics and Treatment Protocol
Fifty-three patients (n = 53) with head and neck tumors undergoing chemoradiation therapy participated in this study with the signed consents approved by the
University of Kentucky Institutional Review Board. Based on the detection limitation in
tumor size for optical measurements, we included Stage III-IVb SCCHN with a cervical
tumor node larger than 2 cm in the longitudinal dimension. Tumor location and size were
identified by MRI, CT and/or ultrasound imaging. Patients with supraclavicular
adenopathy were not enrolled as there was a possibility of the primary origin from other
sites in the chest such as lung or esophagus.
Each patient received daily fractional radiation over 7 weeks. A total dose of 70
Gy was delivered in once daily fractions of 2 Gy, and in the form of high-energy X-ray
beams (6 MV) produced by a medical linear accelerator (Clinac 21EX, Varian Medical
Systems, USA). Radiotherapy in combination with traditional chemotherapy was applied
on these patients. The cisplatin was given at 100 mg/m2 on Day 1 and Day 22 of
radiation. The role of chemotherapy (cisplatin) in head/neck cancer was to increase the
incidence of double strand breaks (radiosensitization) and decrease the incidence of
metastatic diseases.
5.2.3. Experimental Protocols
Prior to treatment, clinical exams of HPV-16 status and hemoglobin concentration
of blood samples were collected. The biggest clinically involved cervical lymph node
was identified by MRI or CT imaging as the measured target and then the tumor node
volume and location were quantified. The optical measurement protocol consisted of a
pre-treatment measurement as baseline and weekly measurements (once per week) over
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the entire treatment period of 7 weeks (Fig. 5.1a). Before each measurement, an
ultrasound machine (Mindray M5, Mindray, China) was used to verify the location and
size of the tumor node. The Imagent was calibrated using a solid phantom with known
optical properties (µa and µs’).
The optical measurement was then continuously taken by placing the hybrid fiberoptic probe on the surface of the selected lymph node (Fig. 5.1b) for 3 minutes with a
sampling rate of 0.25 Hz, followed by taking a measurement on the forearm flexor
muscle for 2 minutes as a control for comparison. Data obtained over the measurement
period were averaged and mean values were used to represent tumor optical properties
and hemodynamics.
Clinical outcome assessments such as tumor volume change, local control, remote
metastasis, and/or local recurrence were conducted every three months after completing
the chemo-radiation therapy.
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Figure 5.1 Measurement setup and protocol: (a) chemo-radiation therapy protocol and
measurement procedures and (b) optical measurement (left) using a hybrid Imagent/DCS
instrument (right).
5.2.4 Data Analysis and Presentation
Table 5.1 Patient/tumor characteristics based on HPV-16 status and treatment outcomes
All Patients

HPV-16 Positive

HPV-16 Negative

CR

IR

Patients

Patients

Patients

Patients

59.11 ±1.50

59.73 ±2.20

58.22 ±

59.36 ±

1.60

2.09

Age
mean ±SE (yrs)

58.59 ±1.28

Gender
Male

29 (3*)

18

8

21

8

Female

5 (1*)

1

3

2

3

13.94 ±0.27

14.03 ±0.37

13.64 ±0.46

14.18 ±

13.43 ±

0.34

0.39

Hemoglobin
mean ±SE (g/dL)

Primary Tumor Site
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Base of tongue

10 (1*)

6

3

7

3

Larynx

8

1

7

5

3

Tonsil

14 (2*)

12

0

9

5

Unknown primary

2 (1*)

0

1

2

0

Tx + T0-2

12 (3*)

6

3

9

3

T3-4

22 (1*)

13

8

14

8

N1

0

0

0

0

0

N2-3

34 (4*)

19

11

23

11

23.98 ±3.97

30.90 ±6.16

17.80 ±4.14

20.93 ±

30.38 ±

3.67

9.26

11.70 ±

11.75 ±

0.97

2.84

Tumor Stage

N stage

Tumor Node Size
mean ±SE (cm3)

Cutaneous Tissue Thickness
mean ±SE (mm)

11.71 ±1.13

12.17 ±1.28

10.73 ±2.63

* indicates the number of patients without testing HPV-16 status.

Patients were classified into two groups based on clinical outcomes: a complete
response (CR) and an incomplete response (IR) group with the remote metastasis and/or
local recurrence within one year after radiation therapy. Although 53 patients were
measured, so far only 40 patients have one-year follow-up treatment outcome results.
Among these 40 patients, one was withdrawn from study at request of the patient and five
did not have pretreatment measurements due to instrument issues. Therefore, 34 patients
were included in our data analysis (see Table 5.1). The optical measurements over the
entire treatment courses of 7 weeks were not always available for each individual due to
patient-related issues such as side effects of treatment, fatigue, non-compliance with
chemo-radiation regimen or due to time constraints of obtaining measurements and
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modification of treatment schedules as a consequence of temporary breakdown in
radiation therapy equipment. Therefore, we marked the number of valid measurements at
each week in figures. Data obtained beyond 4 weeks of the treatment were also excluded
because majority of tumor nodes became too small (due to radiation therapy) to be
visible/measurable by the optical technique.
Student's t tests were used to compare the differences between groups in age,
pretreatment hemoglobin level in blood sample, tumor node size, and cutaneous tissue
thickness above the tumor (Table 5.1). The criterion for significance was p < 0.05.
To compare the time course tumor hemodynamic responses to therapy between
the CR and IR groups and between HPV-16 positive and HPV-16 negative groups, we
used linear mixed models [142] with fixed effects of time (as categorical), group (CR/IR
or HPV-16 positive/HPV-16 negative), and their interaction and banded covariance
structures. Based on the linear mixed model for each hemodynamic parameter, an overall
test was first constructed to assess whether there were differences in that parameter
between groups at any time point. In the case of a significant overall test, post hoc
pairwise comparisons were then conducted at each time point and the Holm's procedure
was used to adjust for multiple comparisons. A p value less than 0.05 was considered
significant.
The predictive values of different optical measurements can vary over time.
Receiver operating characteristic (ROC) curves were constructed and the areas under the
ROC curves (AUC) were calculated to evaluate the abilities of various diffuse optical
parameters at different weeks for discriminating the CR and IR groups. The bootstrap
method [154] with 500 bootstrap samples was used to obtain the 95% confidence interval
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(CI) of the AUC. A 95% CI of AUC not including 0.5 indicates a significant result. The
statistical analyses were performed by SAS 9.3 and R software version 3.0.1.
Particularly, the ROCR package was used to calculate the AUC.
5.3 Results
The differences in tumor hemodynamic responses to chemo-radiation therapy
between the IR and CR groups were firstly compared without considering the effects of
HPV-16 status (Section 5.3.1). We then refined comparisons by separating patients to
HPV-16 positive group or HPV-16 negative group, and reported the results in Section
5.3.2 and Section 5.3.3, respectively. Based on these results, we summarized prognostic
values of the measured parameters for one-year treatment outcomes (Section 5.3.4).
Finally, we compared the differences in tumor hemodynamic responses and treatment
outcomes between the HPV-16 positive and HPV-16 negative groups (Section 5.3.5).
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5.3.1 Overall Tumor Responses to Therapy without Considering HPV-16 Status

Figure 5.2 Averaged values (means ± standard errors) of hemodynamic and diffuse
optical parameters in tumor nodes without considering HPV-16 status grouped by
incomplete response (IR) and complete response (CR): (a) blood flow index (BFI or
αDB), (b) oxygenated hemoglobin concentration ([HbO2]), (c) total hemoglobin
concentration (THC), (d) reduced scattering coefficient (μs’), (e) deoxygenated
hemoglobin concentration ([Hb]), and (f) blood oxygen saturation (StO2) in tumor nodes
at different weeks. Note that p-values derived from the linear mixed-effects model for
overall differences between the IR and CR groups are shown. The numbers shown at
each week represent the valid measurements in IR and CR patients, respectively.

Figure 5.2 shows the dynamic changes of optical properties and tissue
hemodynamics over the treatment period of the first 4 weeks, measured in the tumor
nodes without considering HPV-16 status. Overall, there were significant differences in
[HbO2] and StO2 between the IR and CR groups (p = 0.04 and 0.01, respectively).
However, post hoc pairwise tests didn’t find any significant difference in any parameter
at any measurement time point between the two groups.
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For control measurements in forearms, no significant difference in either overall
the treatment period or at any time measurement time point was found between the two
groups (data are not shown). There were no significant baseline differences prior to the
treatment in age, hemoglobin level of blood sample, tumor node size, and cutaneous
tissue thickness above the tumor between the CR and IR groups (Table 5.1).
5.3.2 Comparison of Tumor Hemodynamic Responses between IR and CR Groups in
HPV-16 Positive Patients

Figure 5.3 Averaged values (means ± standard errors) of hemodynamic and diffuse
optical parameters in HPV-16 positive patients grouped by IR and CR: (a) BFI (αDB), (b)
[HbO2]), (c) THC, (d) μs’, (e) [Hb], and (f) StO2 in tumor nodes at different weeks. Note
that p-values derived from the linear mixed-effects model for overall differences between
the IR and CR groups are shown. The numbers shown at each week represent the valid
measurements in IR and CR patients, respectively. Significant differences at 0.01 and
0.05 levels between groups derived from pairwise comparisons at different time points
are indicated with ** and * respectively.
Dynamic changes of optical properties and tissue hemodynamics in tumor nodes
of HPV-16 positive patients in response to therapy are summarized in Fig. 5.3. Overall,
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there were significant differences in [HbO2] (Fig. 5.3b), THC (Fig. 5.3c), and StO2 (Fig.
5.3f) between the IR and CR groups (p = 0.003, 0.03, 0.01, respectively). Post hoc
pairwise tests demonstrated that the IR group had significant lower levels in [HbO2] at
Week 1 (Fig. 5.3b) and StO2 at Week 3 (Fig. 5.3f) at Week 1 and Week 3, respectively,
compared to the CR group (p = 0.02 and 0.03 respectively).
In HPV-16 positive patients, only forearm StO2 in the IR group showed an overall
significantly lower level than the CR group (p = 0.04, data are not shown). However, post
hoc pairwise tests didn’t find any significant difference in forearms at any measurement
time point between the two groups.
5.3.3 Comparison of Tumor Hemodynamic Responses between the IR and CR Groups in
HPV-16 Negative Patients

Figure 5.4 Averaged values (means ± standard errors) of hemodynamic and diffuse
optical parameters in tumor nodes in HPV-16 negative patients grouped by incomplete
response (IR) and complete response (CR): (a) BFI (αDB), (b) oxygenated hemoglobin
concentration ([HbO2]), (c) total hemoglobin concentration (THC), (d) reduced scattering
coefficient (μs’), (e) deoxygenated hemoglobin concentration ([Hb]), and (f) blood
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oxygen saturation (StO2) in tumor nodes at different weeks. Significant differences at
0.01 and 0.05 levels between groups derived from pairwise comparisons at different time
points are indicated with ** and * respectively.
Figure 5.4 shows the dynamic changes of optical properties and tissue
hemodynamics in tumor nodes in response to therapy in HPV-16 negative patients.
Overall, there were significant differences in BFI (Fig. 5.4a) and μs’ (Fig. 5.4d) between
the two groups (p = 0.007 and 0.0005, respectively). Post hoc pairwise tests demonstrated
that the mean BFI at Week 3 (p = 0.0007) and μs’ at Week 3 and Week 4 (p = 0.01 and
0.03 respectively) in the IR group were significantly higher than those in the CR group.
For the control measurements in forearms, no significant difference in either
overall treatment period or at any measurement time point was found between the two
groups (data are not shown).
5.3.4 Time-Specific Receiver Operating Characteristic Curves for Predicting Treatment
Outcomes
Table 5.2 Summary of time-specific AUC estimates (95% confidence interval) of the
measured parameters for the prediction of treatment outcomes in HPV-16
positive/negative patients
Baseline

Week 1

Week 2

Week 3

Week 4

HPV-16 Positive Patients
[HbO2]

0.54 (0.25, 0.82)

0.93 (0.72, 1.00)

0.82 (0.56, 1.00)

0.82 (0.57, 1.00)

0.67 (0.24, 1.00)

StO2

0.61 (0.27, 0.90)

0.80 (0.52, 1.00)

0.69 (0.35, 0.96)

0.85(0.56, 1.00)

0.63 (0.23, 0.97)

HPV-16 Negative Patients
BFI

0.54 (0.13, 0.89)

0.62 (0.25, 0.98)

0.75 (0.40, 1.00)

1.00 (1.00, 1.00)

0.67 (0.17, 1.00)

μs’

0.82 (0.52, 1.00)

0.91 (0.63, 1.00)

0.83 (0.50, 1.00)

0.95 (0.75, 1.00)

0.87 (0.57, 1.00)

90

Figure 5.5 Receiver operating characteristic curves (ROC) and their associated areas
under the curve (AUC) for discriminating tumors with incomplete or complete responses.
(a) [HbO2] at Week 1 in HPV-16 positive patients, (b) StO2 at Week 3 in HPV-16
positive patients, (c) BFI in HPV-16 negative patients at Week 3 and (d) μs’ in HPV-16
negative patients at Week 3.

To evaluate the predictive values of hemodynamic parameters over the treatment
period, we calculated time-specific ROC curves utilizing optical measurements obtained
at different weeks. Table 5.2 and Fig. 5.5 summarize the ROC results for the parameters
showing predictive ability to differentiate IR tumors from CR tumors. The results
underlined in the table are considered to have good predictive ability for treatment
outcomes. Figure 5.6 shows representative ROC curves for discriminating tumors with
incomplete or complete responses.
In HPV-16 positive patients, [HbO2] provided the best prediction of treatment
outcomes at Week 1 (AUC = 0.93 [95% CI: 0.72-1.00]). StO2 also showed a moderate
prediction of treatment outcomes at Week 3 (AUC = 0.85 [95% CI: 0.56-1.00]). In HPV-
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16 negative patients, BFI and μs’ provided excellent predictions of treatment outcomes at
Week 3 (AUC = 1.00 [95% CI 1.00-1.00] and 0.95 [95% CI 0.75-1.00] respectively). In
particular, μs’ values over the first 4 weeks of treatment period demonstrate consistent
predictive ability for treatment outcomes.
5.3.5 Comparisons of Tumor Hemodynamic Responses between the HPV-16 Positive
Group and HPV-16 Negative Group
There were no significant baseline differences prior to the treatment in age,
hemoglobin level of blood sample, tumor node size, and cutaneous tissue thickness above
the tumor between the HPV-16 positive group and HPV-16 negative group (Student t
tests in Table 5.1). Overall, there were no significant differences in all measured optical
parameters between the two groups, tested by the linear mixed models (data are not
shown).
5.4 Discussion and Conclusions
This study aimed to test the sensitivity and specificity of tumor hemodynamic
parameters for early prediction of chemo-radiation therapy outcomes in patients with
head and neck cancer. We utilized a novel hybrid diffuse optical instrument developed in
our laboratory and measured dynamic changes in tumor optical properties and
hemodynamics weekly over the treatment period. We examined the predictive values of
multiple parameters measured in local tumors including BFI, μs’, [HbO2], [Hb], THC,
and StO2 in relation to one-year treatment outcomes. In addition, we also collected other
information about the patients including ages, tumor volumes, hemoglobin levels in
blood samples and hemodynamic changes in forearm muscles over the treatment period.
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No significant baseline differences prior to the treatment in age, hemoglobin level
of blood sample, tumor node size, and cutaneous tissue thickness between the CR and IR
groups (see Table 5.1), suggesting insignificant influences of these factors on treatment
outcomes. Forearm hemodynamics didn’t show a significant difference at any
measurement time point between the CR and IR groups, indicating insignificant impacts
of chemo-radiation therapy on tissues outside the radiation beam.
Based on the overall results from 34 patients, we observed significant differences
in tumor [HbO2] and StO2 between the IR and CR groups over the treatment period.
However, post hoc pairwise tests could not find any significant difference at any specific
measurement time point (see Fig. 5.2). Interestingly, after breaking down the patients into
subgroups of HPV-16 positive and HPV-16 negative, we found significant differences in
some of the measured parameters between the IR and CR groups.
In HPV-16 positive patients, IR tumors showed significant lower levels of [HbO2]
and StO2 compared to the CR tumors at Week 1 and Week 3 (see Fig. 5.3). These results
agree with previous observations that HNSCC with insufficient oxygen has poor
treatment outcomes [20-29].
In HPV-16 negative patients, IR tumors showed a continual increase in BFI and
consistently higher values in μs’ compared to CR tumors over the first 4 weeks of the
treatment period (see Fig. 5.4); significant higher levels in BFI at Week 3 and μs’ at
Week 3 and Week 4 were observed in IR tumors. These results are consistent with some
reported findings. Previously, high angiogenesis has been found to be related to poor
local control rate in head and neck cancers under radiation therapy [155, 156]. Dynamic
blood flow increases during radiation therapy have also been observed in head and neck

93

tumors with incomplete responses [88, 157]. The significant higher levels of BFI and μs’
in IR tumors may be associated with more active angiogenesis which forms defective
vascular networks, leading to blood leakiness inside tumors and poor efficiency in
oxygen supply. In addition, a higher blood flow level may be attributed to a higher upregulation of vascular endothelial growth factor in IR tumor cells than in CR tumor cells,
which promotes the survival of endothelial cells and thereby radiation resistance [158].
Also, higher expression of endothelial nitric oxide in IR tumors may further enhance
blood perfusion, open up nonperfused vessels, and promote neoangiogenesis [157, 159].
In this study we found that different parameters have different sensitivity and
specificity in predicting treatment outcomes (see Table 5.2 and Fig. 5.5). For example,
[HbO2] and StO2 show prognostic values for predicting treatment outcomes in HPV-16
positive patients while BFI and μs’ provide the best prediction of treatment outcomes in
HPV-16 negative patients. Although the differences between HPV-16 positive and HPV16 negative patients in tumor gene mutations [160], tumor microenvironment [161],
metabolic profile [162], angiogenesis [163], and adaptation to hypoxia may have impacts
on treatment outcomes, exact pathogenic mechanisms underlying these differences need
further investigations.
In summary, our diffuse optical measurements show great potential for early
(within the first 3 weeks of treatment period) prediction of chemo-radiation therapy in
patients with head and neck cancer. Since HPV-16 status affects tumor responses to
therapy, subgrouping patients based on HPV-16 status can improve the prediction of
treatment outcomes. More patients are being recruited to increase statistical power of data
analysis and for developing a predictive model integrating multiple parameters to
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improve the sensitivity and specificity of prediction. Ultimately, reduction of side effects
in patients not benefiting from chemo-radiation therapy may be feasible through early
predicting the incomplete responses.
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CHAPTER 6 STUDY SUMMARY, LIMITATIONS, AND FUTURE
PERSPECTIVES
In this dissertation, I present study motivation, theoretical background, technical
development, and clinical application results for longitudinal monitoring of
hemodynamic responses to chemo-radiation therapy in head and neck tumors using nearinfrared diffuse optical technologies. During the study, I overcome a number of technical
challenges in adapting our novel hybrid diffuse optical techniques for simultaneous
measurements of tumor blood flow and oxygenation during chemo-radiation therapy in
HNSCC.
My major contributions include: (A) participating in the development of the
hybrid diffuse optical instrument combining a commercial tissue oximeter (Imagent) and
custom-made DCS as well as the novel portable dual-wavelength DCS flow-oximeter
(Chapter 2) [85]; (B) comprehensively investigating the possibility of fitting multiple
parameters from the measured one single autocorrelation curve of DCS and evaluating
the accuracy and performance of the two fitting methods with computer simulations,
tissue-like phantom experiments, and in-vivo tissue measurements (Chapter 3) [134]; (C)
identifying and overcoming measurement artifacts induced by scattered X-rays and
applying the remotely controlled DCS flow-oximeter in the treatment room for the first
continuous measurements of tumor hemodynamic changes during x-ray radiation
delivery (Chapter 4) [116]; (D) continually monitoring tumor optical and hemodynamic
status over 7 weeks of treatment period (Chapter 5), and (E) discovering the impacts of
tumor HPV status on hemodynamic responses to the treatment and quantifying the
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sensitivity and specificity of multiple hemodynamic parameters for early prediction of
treatment outcomes in HNSCC (Chapter 5).
More specifically, we observed a large crosstalk between αDB and μa or αDB and
μs’, which can greatly affect the accuracy in extracting BFI (αDB) of DCS [111]. My
study revealed that these paired parameters can compensate each other to generate a
similar autocorrelation curve (Chapter 3.4). In contrast, β did not compensate the
variation of αDB and thus simultaneous fitting of β and αDB was feasible and generated
more accurate estimations of these parameters with smaller standard deviations (Chapter
3). On the other hand, our hybrid diffuse optical instrument (Imagent/DCS) allowed to
quantify the absolute values of μa and μs’. Using these optical properties as inputs and our
novel simultaneously fitting method, β and αDB can be accurately quantified (Chapter 2
and Chapter 3). Through phantom tests, I found that artifacts caused by scattered x rays
can be avoided by moving the optical device away from the x-ray beams (Chapter 4). A
significant increase in tumor blood flow was observed at the first two weeks of treatment
and only small changes were found in tumor blood oxygenation during radiation delivery
(Chapter 4). Interestingly, I found that human papilloma virus (HPV-16) status largely
affected tumor homodynamic responses to therapy and different parameters had different
sensitivity and specificity in predicting treatment outcomes in HPV-16 positive patients
or HPV-16 negative patients. By grouping patients according to HPV-16 status, I found
some of these hemodynamic parameters were sensitive and specific for early
identification of incomplete responders to chemo-radiation therapy (Chapter 5).
It should be noted that our results and conclusions should be interpreted with
caution due to the limited numbers of patients and measurements. More patients are
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needed to increase the statistical power for data analysis and to develop predictive models
integrating multiple parameters for better prediction of individual treatment outcomes.
As described in Chapter 1, assessment of tumor heterogeneity is also potential
biomarker for tumor characterization and treatment response prediction. The nearinfrared spectroscopies used in this study have the limited spatial resolution. Nearinfrared (NIR) imaging technologies such as diffuse optical/correlation tomography
(DOT/DCT) [164] should be explored in the future to quantify hemodynamic
heterogeneity in tumor.
I expect that with further technology development and large population
measurements, our hybrid diffuse optical techniques with multiple-parameter outputs will
provide valuable information for early prediction of radiation therapy outcomes.
Ultimately, reduction of side effects in patients not benefiting from radiation treatment
will be feasible.
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GLOSSARY
SYMBOLS
α

Ratio of Dynamic to Static Scatterers (0 - 1)

ac

Modulated Light Amplitude

β

Coherence Factor

c

Hemoglobin Concentration of Whole Blood

γ

Percentage of Blood Volume Contained in the Venous Compartment

D

Photon Diffusion Constant

DB

Effective Diffusion Coefficient

Φdc

Average Light Intensity

Φac

Peak-to-peak Light Intensity

g1

Normalized Electric Field Temporal Autocorrelation Function

G1

Unnormalized Electric Field Temporal Autocorrelation Function

g2

Normalized Intensity Temporal Autocorrelation Function

I

Intensity

k0

Wavevector of Photons in Medium (k0 = 2π /λ)

kB

Boltzmann Constant

λ

Wavelength

n

Ratio of Sample and Air Index of Refraction

φ

Phase Shift Between the Detected and Source NIR Light

ɛ

Extinction Eoeficient

R·

DNA free radical

r

Position Vector
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ρ

Source-detector Separation

<Δr2(τ) >

Mean-square Particle Displacement in Time τ

SAC

Slope of ρ vs. AC component light intensity Curve

SDC

Slope of ρ vs. DC component light intensity Curve

Sφ

Slope of ρ vs. Phase shift Curve

S0

Source-light Distribution

τ

Correlation Function Decay Time

μa

Absorption Coefficient

μs’

Reduced Scattering Coefficient

v

Speed of Light in Medium

ω

Angular Frequency of Modulation

TERMS
[Hb]

deoxygenated hemoglobin concentration (unit μM)

[HbO2]

oxygenated hemoglobin concentration (unit μM)

Δ[Hb]

deoxygenated hemoglobin concentration change (unit μM)

Δ[HbO2]

oxygenated hemoglobin concentration change (unit μM)

ΔTHC

total hemoglobin concentration change (unit μM)

ADC

Apparent Diffusion Coefficient

APD

Avalanche Photodiode

ASL-MRI

Arterial Spin-Labeled Magnetic Resonance Imaging (Perfusion MRI)

BFI

Blood Flow Index (αDB)

BF

Blood Flow
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BOLD-MRI

Blood Oxygen Level Dependent Magnetic Resonance Imaging

BV

Blood Volume

CR

Complete Response

CT

Computed Tomography

CW

Continuous Wave

DPF

Differential Pathlength Factor

DCE

Dynamic Contrast-Enhanced

DCS

Diffuse Correlation Spectroscopy

DOS

Diffuse Optical Spectroscopy

DWI

Diffusion-Weighted Imaging

DWS

Diffusing Wave Spectroscopy

OER

Oxygen Enhancement Ratio

FD

Frequency-Domain

Hb

Deoxygenated hemoglobin

HbO2

Oxygenated hemoglobin

HNSCC

Head and Neck Squamous Cell Carcinoma

HPV

Human Papillomavirus

IR

Incomplete Response

LDF

Laser Doppler Flowmetry

LET

Linear Energy Transfer

MR

Magnetic Resonance

NIR

Near-Infrared

OD

Optical Density
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PDT

Photodynamic Therapy

PET

Positron Emission Tomography

PMT

Photomultiplier Tube

RBC

Red Blood Cell

SPECT

Single-Photon Emission Computed Tomography

SNR

Signal to Noise Ratio

SSD

Sum of Squared Differences

StO2

Tissue Blood Oxygen Saturation

THC

Total Hemoglobin Concentration

TR

Time-Resolved

TTL

Transistor–Transistor Logic
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